Francis A. Farraye, M.D., M.S.

  1. Gastroenterologist
  1. Desai A, Sehgal P, Khataniar H, Lewis JD, Farraye FA, Lichtenstein GR, Kochhar GS. Obesity Is Associated With Worsened Outcomes in Patients With Ulcerative Colitis on Advanced Therapies: A Propensity Matched Cohort Study From the U.S. Aliment Pharmacol Ther. 2025 Apr; 61 (7):1197-1207 Epub 2025 Jan 22
    View PubMed
  2. Alsakarneh S, Ramirez OR, Hayney MS, Hashash JG, Farraye FA, Caldera F. Patients With Inflammatory Bowel Disease Are At Increased Risk Of Respiratory Syncytial Virus Infections post-SARS-CoV2 Infection: A Propensity-Matched Cohort Analysis. Clin Transl Gastroenterol. 2025 Mar 27 [Epub ahead of print]
    View PubMed
  3. Caldera F, Hayney MS, Farraye FA, Fischer M, Xu H, Kappelman MD. Low incidence of Varicella in Pediatric Patients with Inflammatory Bowel Disease. Am J Gastroenterol. 2025 Mar 18 [Epub ahead of print]
    View PubMed
  4. Desai A, Khataniar H, Hashash JG, Farraye FA, Regueiro M, Kochhar GS. Effectiveness and Safety of Semaglutide for Weight Loss in Patients With Inflammatory Bowel Disease and Obesity. Inflamm Bowel Dis. 2025 Mar 3; 31 (3):696-705
    View PubMed
  5. Karime C, Salazar M, Black CN, Caldera F, Okafor PN, Hammami MB, Hashash JG, Farraye FA. In Patients With Inflammatory Bowel Disease, Racial Disparities Exist in Burden of Vaccine-preventable Disease Hospitalizations and Outcomes. J Clin Gastroenterol. 2025 Mar 1; 59 (3):237-244 Epub 2025 Mar 01
    View PubMed
  6. Danpanichkul P, Duangsonk K, Ho AHY, Laoveeravat P, Vuthithammee C, Dejvajara D, Prasitsumrit V, Auttapracha T, Songtanin B, Wetwittayakhlang P, Lui RN, Kochhar GS, Ng SC, Farraye FA, Wijarnpreecha K. Disproportionately Increasing Incidence of Inflammatory Bowel Disease in Female Patients and the Elderly: An Update Analysis from the Global Burden of Disease Study 2021. Am J Gastroenterol. 2025 Mar 1; 120 (3):675-680 Epub 2024 Oct 18
    View PubMed
  7. Alsakarneh S, Hashash JG, Farraye FA, Ghoz H. Reply to Ching-Pin et al. Am J Gastroenterol. 2025 Mar 1; 120 (3):682 Epub 2024 Oct 24
    View PubMed
  8. Fiorino G, Ananthakrishnan A, Cohen RD, Cross RK, Deepak P, Farraye FA, Halfvarson J, Steinhart AH. Accelerating Earlier Access to Anti-TNF-alpha Agents with Biosimilar Medicines in the Management of Inflammatory Bowel Disease. J Clin Med. 2025 Feb 26; 14 (5)
    View PubMed
  9. Alsakarneh S, Desai A, Kochhar GS, Farraye FA, Hashash JG. Treatment of Chronic Pouchitis With JAK Inhibitors: Results from A Large Multicenter Database. Inflamm Bowel Dis. 2025 Feb 6; 31 (2):597-600
    View PubMed
  10. Wang Y, Pan CW, Huang Y, Zheng X, Li S, He M, Hashash JG, Farraye FA, Ehrlich AC. Global Epidemiology and Geographic Variations of Pediatric-Onset Inflammatory Bowel Disease: A Comprehensive Analysis of the Global Burden of Disease Study 1990 to 2019. Inflamm Bowel Dis. 2025 Feb 6; 31 (2):376-385
    View PubMed
  11. Odah T, Vattikonda A, Stark M, Brahmbhatt B, Lukens FJ, Badurdeen D, Hashash JG, Farraye FA. Glucagon-like peptide-1 receptor agonists and capsule endoscopy in patients with diabetes: a matched cohort study. Gastrointest Endosc. 2025 Feb; 101 (2):393-401 Epub 2024 July 31
    View PubMed
  12. Shen B, Abreu MT, Cohen ER, Farraye FA, Fischer M, Feuerstadt P, Kapur S, Ko HM, Kochhar GS, Liu X, Mahadevan U, McBride DL, Navaneethan U, Regueiro M, Ritter T, Sharma P, Lichtenstein GR, ASGE IBD Endoscopy Consensus Panel. Endoscopic diagnosis and management of adult inflammatory bowel disease: a consensus document from the American Society for Gastrointestinal Endoscopy IBD Endoscopy Consensus Panel. Gastrointest Endosc. 2025 Feb; 101 (2):295-314 Epub 2024 Oct 18
    View PubMed
  13. Caldera F, Singh S, Zona EE, Ramirez OR, Ramirez Ramirez O, Inselman J, Heien H, Keaveny AP, Hayney MS, Farraye FA. Patients With Inflammatory Bowel Disease Are at Increased Risk for Complications of Herpes Zoster. Clin Gastroenterol Hepatol. 2025 Feb; 23 (2):331-340.e2 Epub 2024 Oct 24
    View PubMed
  14. Danpanichkul P, Duangsonk K, Lopimpisuth C, Ho AH, Fangsaard P, Sukphutanan B, Pang Y, Chaisrimaneepan N, Dejvajara D, Suenghataiphorn T, Worapongpaiboon R, Chaiyakunapruk N, Lui RN, Kochhar GS, Ng SC, Farraye FA, Wijarnpreecha K. Geographical and sociodemographic epidemiology of inflammatory bowel disease in young females from 2010 to 2019. Dig Liver Dis. 2025 Jan; 57 (1):190-197 Epub 2024 July 26
    View PubMed
  15. Ghusn W, Mourad FH, Francis FF, Pasha S, Farraye FA, Hashash JG. The Use of Immunomodulators, Biologic Therapies, and Small Molecules in Patients With Inflammatory Bowel Disease and Solid Organ Transplant. J Clin Gastroenterol. 2025 Jan 1; 59 (1):24-35 Epub 2025 Jan 01
    View PubMed
  16. Ramirez OR, Farraye FA, Hayney MS, Caldera F. Inadvertent live vaccine administration in adult patients with inflammatory bowel disease on immunosuppressive therapy. Vaccine. 2024 Dec 2; 42 (26):126319 Epub 2024 Sept 07
    View PubMed
  17. Kochhar GS, Khataniar H, Jairath V, Farraye FA, Desai A. Comparative Effectiveness of Upadacitinib and Tofacitinib in Ulcerative Colitis: A US Propensity-Matched Cohort Study. Am J Gastroenterol. 2024 Dec 1; 119 (12):2471-2479 Epub 2024 July 05
    View PubMed
  18. Limdi JK, Rhodes S, Liu E, Kuriakose Kuzhiyanjal AJ, Brookes M, Farraye J, Cannon R, Woodhams E, Farraye FA. Knowledge, Values and Preferences regarding Contraceptive Choices among Women living with Inflammatory Bowel Disease. J Crohns Colitis. 2024 Nov 27 [Epub ahead of print]
    View PubMed
  19. Hashash JG, Yu Ci Ng F, Farraye FA, Wang Y, Colucci DR, Baxi S, Muneer S, Reddan M, Shingru P, Melmed GY. Inter- and Intraobserver Variability on Endoscopic Scoring Systems in Crohn's Disease and Ulcerative Colitis: A Systematic Review and Meta-Analysis. Inflamm Bowel Dis. 2024 Nov 4; 30 (11):2217-2226
    View PubMed
  20. Barnes EL, Desai A, Hashash JG, Farraye FA, Kochhar GS. The Natural History After Ileal Pouch-Anal Anastomosis for Ulcerative Colitis: A Population-Based Cohort Study From the United States. Am J Gastroenterol. 2024 Nov 1; 119 (11):2267-2274 Epub 2024 June 18
    View PubMed
  21. Buchner AM, Farraye FA, Iacucci M. AGA Clinical Practice Update on Endoscopic Scoring Systems in Inflammatory Bowel Disease: Commentary. Clin Gastroenterol Hepatol. 2024 Nov; 22 (11):2188-2196 Epub 2024 Sept 20
    View PubMed
  22. Vora H, Ibrahim R, Chan J, Farraye FA, Hashash JG. Are biopsies from endoscopically normal terminal ileum necessary? Ann Gastroenterol. 2024 Nov-Dec; 37 (6):695-698 Epub 2024 Oct 29
    View PubMed
  23. Kochhar GS, Khataniar H, Hashash JG, Tabaku F, Regueiro M, Farraye FA, Desai A. Comparative Effectiveness of Ozanimod and Vedolizumab as First-Line Advanced Therapies in Ulcerative Colitis: A Propensity-Matched Cohort Analysis. Inflamm Bowel Dis. 2024 Oct 30 [Epub ahead of print]
    View PubMed
  24. Kastl AJ, Brenner EJ, Weaver KN, Zhang X, Strople JA, Adler J, Dubinsky MC, Bousvaros A, Watkins R, Dai X, Chen W, Cross RK, Higgins PDR, Ungaro RC, Bewtra M, Bellaguarda EA, Farraye FA, Chun KY, Zikry M, Bastidas M, Firestine AM, Craig RG, Boccieri ME, Long MD, Kappelman MD. Durable Immune Response and Long-term Efficacy of COVID-19 Vaccination in Children With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2024 Oct 16 [Epub ahead of print]
    View PubMed
  25. Odah T, Karime C, Hashash JG, Kinnucan JA, Picco MF, Farraye FA. The Utility of Patency Capsule in Patients With Crohn's Disease. J Clin Gastroenterol. 2024 Oct 15 [Epub ahead of print]
    View PubMed
  26. Karime C, Black CN, Cortes P, Kwon JY, Caldera F, Crosby SK, Picco MF, Kinnucan JA, Hashash JG, Farraye FA. Utility of a Third Heplisav-B Dose in Patients With Inflammatory Bowel Disease Without Immunity After 2-Dose Heplisav-B Vaccination. Am J Gastroenterol. 2024 Oct 1; 119 (10):2079-2085 Epub 2024 May 08
    View PubMed
  27. Odah T, Karime C, Desai A, Picco MF, Kinnucan JA, Hashash JG, Farraye FA. Response to Upadacitinib in Patients with Inflammatory Bowel Disease Previously Treated with Tofacitinib. Dig Dis Sci. 2024 Oct; 69 (10):3911-3919 Epub 2024 Sept 09
    View PubMed
  28. Schell TL, Fass L, Hitchcock ME, Farraye FA, Hayney MS, Saha S, Caldera F. Safety of Rotavirus Vaccination in Infants That Were Exposed to Biologics In Utero: A Systematic Review. Inflamm Bowel Dis. 2024 Sep 20 Epub 2024 Sept 20
    View PubMed
  29. Desai A, Petrov J, Hashash JG, Patel H, Brahmbhatt B, Kochhar GS, Farraye FA. Use of glucagon-like peptide-1 receptor agonists for type 2 diabetes mellitus and outcomes of inflammatory bowel disease. Aliment Pharmacol Ther. 2024 Sep; 60 (5):620-632 Epub 2024 June 27
    View PubMed
  30. El Hage Chehade N, Ghoneim S, Shah S, Pardi DS, Farraye FA, Francis FF, Hashash JG. Efficacy and Safety of Vedolizumab and Tumor Necrosis Factor Inhibitors in the Treatment of Steroid-refractory Microscopic Colitis: A Systematic Review and Meta-analysis. J Clin Gastroenterol. 2024 Sep 1; 58 (8):789-799 Epub 2024 Sept 01
    View PubMed
  31. Gnanapandithan K, Stuessel LG, Shen B, Mourad FH, Peng Z, Farraye FA, Hashash JG. Pelvic Radiation Therapy Increases Risk of Pouch Failure in Patients with Inflammatory Bowel Disease and Ileal Pouch. Dig Dis Sci. 2024 Sep; 69 (9):3392-3401 Epub 2024 Aug 01
    View PubMed
  32. Rex DK, Anderson JC, Butterly LF, Day LW, Dominitz JA, Kaltenbach T, Ladabaum U, Levin TR, Shaukat A, Achkar JP, Farraye FA, Kane SV, Shaheen NJ. Quality Indicators for Colonoscopy. Am J Gastroenterol. 2024 Sep 1; 119 (9):1754-1780 Epub 2024 Mar 27
    View PubMed
  33. Rex DK, Anderson JC, Butterly LF, Day LW, Dominitz JA, Kaltenbach T, Ladabaum U, Levin TR, Shaukat A, Achkar JP, Farraye FA, Kane SV, Shaheen NJ. Quality indicators for colonoscopy. Gastrointest Endosc. 2024 Sep; 100 (3):352-381 Epub 2024 Aug 21
    View PubMed
  34. Alsakarneh S, Ahmed M, Jaber F, Abuassi M, Mourad FH, Francis FF, Barada K, Tfayli R, Al-Bawardy B, Farraye FA, Hashash JG. Inflammatory bowel disease burden in the Middle East and North Africa Region: a comprehensive analysis of incidence, prevalence, and mortality from 1990-2019. Ann Gastroenterol. 2024 Sep-Oct; 37 (5):527-535 Epub 2024 Aug 19
    View PubMed
  35. Jaber F, Ayyad M, Alsakarneh S, Alsharaeh T, Salahat AJ, Jaber M, Gangwani MK, Abboud Y, Mohamed I, Ali H, Kilani Y, Farraye FA, Hashash JG. Efficacy and Safety of Interleukin-12/23 and Interleukin-23 Inhibitors for Ulcerative Colitis: A Systematic Review Ad Meta-Analysis of Randomized Controlled Trials. Am J Ther. 2024 Aug 30 [Epub ahead of print]
    View PubMed
  36. Smith RA, Desai A, Barnes EL, Hayney M, Kochhar GS, Hashash JG, Farraye FA, Caldera F. Patients With Inflammatory Bowel Disease Are at Increased Risk of Hospitalization Due to Respiratory Syncytial Virus. Am J Gastroenterol. 2024 Aug 1; 119 (8):1545-1554 Epub 2024 Feb 06
    View PubMed
  37. Ley D, Lazarus S, Forati AM, Farraye FA, Smith R, Hayney MS, Caldera F. High Rates of Seroprotection to Hepatitis B After a Hepatitis B Challenge Dose in Previously Vaccinated Patients with Inflammatory Bowel Disease on Immunosuppressive Therapy. Dig Dis Sci. 2024 Aug; 69 (8):3051-3060 Epub 2024 June 21
    View PubMed
  38. Alsakarneh S, Ahmed M, Azim S, Hashash JG, Farraye FA, Ghoz H. Risk of Small Intestine Cancer in Inflammatory Bowel Disease: A Propensity-Matched Study from a Large Multi-Center Database in the United States. Am J Gastroenterol. 2024 Jul 25 Epub 2024 July 25
    View PubMed
  39. Petrov JC, Desai AA, Kochhar GS, Crosby SK, Kinnucan JA, Picco MF, Hashash JG, Farraye FA. Metformin Is Associated With Improved Inflammatory Bowel Disease Outcomes in Patients With Type 2 Diabetes Mellitus: A Propensity-Matched Cohort Study. Inflamm Bowel Dis. 2024 Jul 12 Epub 2024 July 12
    View PubMed
  40. Desai A, Soni A, Hayney MS, Hashash JG, Kochhar GS, Farraye FA, Caldera F. Increased Risk of Herpes Zoster in Adult Patients with Inflammatory Bowel Disease After SARS-CoV2 Infection: A Propensity-Matched Cohort Study. Inflamm Bowel Dis. 2024 Jul 3; 30 (7):1094-1102
    View PubMed
  41. Brenner EJ, Weaver KN, Zhang X, Kastl AJ, Strople JA, Adler J, Dubinsky MC, Bousvaros A, Watkins R, Dai X, Chen W, Cross RK, Higgins PDR, Ungaro RC, Bewtra M, Bellaguarda EA, Farraye FA, Chun KY, Zikry M, Bastidas M, Firestine A, Craig RG, Boccieri ME, Long MD, Kappelman MD. Long-Term Effectiveness and Durability of COVID-19 Vaccination Among Patients With Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2024 Jul; 22 (7):1475-1486.e4 Epub 2024 Feb 17
    View PubMed
  42. Alsakarneh S, Hassan K, Jaber F, Mintz M, Zulqarnian M, Obeid A, Ghoz H, Hashash JG, Farraye FA. The national burden of inflammatory bowel disease in the United States from 1990-2019: results from the Global Burden of Disease study database. Ann Gastroenterol. 2024 Jul-Aug; 37 (4):427-435 Epub 2024 June 14
    View PubMed
  43. Alsakarneh S, Ahmed M, Jaber F, Zulqarnain M, Karagozian R, Francis F, Farraye FA, Hashash JG. Does Timing of Ileal Pouch-Anal Anastomosis Matter in Patients With Primary Sclerosing Cholangitis and Orthotopic Liver Transplantation? A Systematic Review and Meta-analysis. Crohns Colitis 360. 2024 Jul; 6(3):otae036. Epub 2024 Jun 21.
    View PubMed
  44. Karime C, Vattikonda A, Hashash JG, Rosser BG, Merchea A, Stocchi L, Farraye FA. Successful Preoperative Transjugular Intrahepatic Portosystemic Shunt for Portal Decompression in Patients With Inflammatory Bowel Disease and Cirrhosis Requiring Surgical Intervention. Crohns Colitis 360. 2024 Jul; 6 (3):otae037 Epub 2024 June 20
    View PubMed
  45. Desai A, Hashash JG, Kochhar GS, Hayney MS, Caldera F, Farraye FA. Recombinant Zoster Vaccine [RZV] is Effective in Patients with Inflammatory Bowel Disease: A US Propensity Matched Cohort Study. J Crohns Colitis. 2024 Jun 3; 18 (6):828-835
    View PubMed
  46. Siu RK, Karime C, Hashash JG, Kinnucan J, Picco MF, Farraye FA. Sirolimus Use in Refractory Crohn's Disease. ACG Case Rep J. 2024 Jun; 11 (6):e01368 Epub 2024 June 14
    View PubMed
  47. Karime C, Hashash JG, Picco MF, Craver EC, Murray JA, Farraye FA. The Effect of Renin-Angiotensin-Aldosterone System Blocking Agents on the Long-term Disease Course of Patients With Crohn's Disease. J Clin Gastroenterol. 2024 May-Jun 01; 58(5):454-463. Epub 2023 Jun 26.
    View PubMed
  48. Karime C, Farraye FA, Hashash JG. Use of Immune Checkpoint Inhibitors in Patients With Inflammatory Bowel Disease After Ileal Pouch-Anal Anastomosis. Inflamm Bowel Dis. 2024 Apr 3; 30 (4):681-685
    View PubMed
  49. Fiske HW, Ward C, Shah SA, Holubar SD, Al-Bawardy B, Barnes EL, Binion D, Bohm M, Brand M, Clarke K, Cohen BL, Cross RK, Dueker J, Engels M, Farraye FA, Fine S, Forster E, Gaidos J, Ginsburg P, Goyal A, Hanson J, Herfath H, Hull T, Kelly CR, Lazarev M, Levy LC, Melia J, Philpott J, Qazi T, Siegel CA, Watson A, Wexner SD, Williams ED, Regueiro M. Clinical Decision Making in Inflammatory Bowel Disease Mimics: Practice Management from Inflammatory Bowel Disease LIVE. Crohns Colitis 360. 2024 Apr; 6 (2):otae022 Epub 2024 Apr 11
    View PubMed
  50. Caldera F, Rolak S, Farraye FA, Necela BM, Cogen D, Zona EE, Schell TL, Ramirez OR, Almasry M, Chun K, Hayney MS, Knutson KL. Higher and Sustained Cell-Mediated Immune Responses After 3 Doses of mRNA COVID-19 Vaccine in Patients With Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor Therapy. Clin Transl Gastroenterol. 2024 Apr 1; 15 (4):e00688 Epub 2024 Apr 01
    View PubMed
  51. Kastl AJ, Weaver KN, Zhang X, Strople JA, Adler J, Kelsen JR, Dubinsky MC, Bousvaros A, Watkins R, Dai C, Cross RK, Higgins PDR, Ungaro R, Bewtra M, Bellaguarda EA, Farraye FA, Chun K, Zikry M, Bastidas M, Boccieri ME, Firestine A, Long MD, Kappelman MD. Humoral immune response and safety of SARS-CoV-2 vaccination in very early onset inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2024 Apr; 78 (4):871-877 Epub 2024 Feb 14
    View PubMed
  52. Bucobo JC, Kassim O, Konijeti GG, Abraham BP, Abegunde AT, Farraye FA, Guha S, Kowalski T, Kumar A, Markowitz AJ, Schoeppner HL, Tierney WM, (ASGE ARIA Committee Chair). Role of the industry representative in the practice of gastroenterology and GI endoscopy. Gastrointest Endosc. 2024 Mar; 99 (3):307-313 Epub 2024 Jan 23
    View PubMed
  53. Odah T, Karime C, Hashash JG, Farraye FA. Nintedanib-Induced Colitis Can Mimic Inflammatory Bowel Disease. ACG Case Rep J. 2024 Feb; 11 (2):e01282 Epub 2024 Feb 08
    View PubMed
  54. Farraye FA. Reviewing Recommendations for Vaccines and Health Care Maintenance in Patients With Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2024 Feb; 20 (2):115-118
    View PubMed
  55. Suilik HA, Jaber F, Abuelazm M, Ramadan A, Elzeftawy MA, Elrosasy A, Youssef RA, Abdelazeem B, Hashash JG, Farraye FA, Ghoz H. Sphingosine 1-phosphate (S1P) receptor modulators as an induction and maintenance therapy for ulcerative colitis: a systematic review and meta-analysis of randomized controlled trials. Inflamm Res. 2024 Feb; 73 (2):183-198 Epub 2023 Dec 28
    View PubMed
  56. Karime C, Crosby S, Bhat S, Hashash JG, Farraye FA. Rapid Adoption of Pneumococcal 20-Valent Conjugate Vaccination in Adult Patients With Inflammatory Bowel Disease: An Analysis One Year After Availability. J Clin Gastroenterol 2024 Feb 1; 58 (2):207-209 Epub 2024 Feb 01
    View PubMed
  57. Santiago P, Coelho-Prabhu N, Lennon R, Rui S, Rajauria P, Friton J, Raffals LE, Deepali F, Daoud N, Farraye FA, Tuck J, Malik T, Leleiko NS, Shapiro J, Shah SA, Sands BE, Ungaro RC. Baseline Clinical Factors Are Associated With Risk of Complications in Crohn's Disease: Appraisal of the American Gastroenterological Association Clinical Care Pathway. Am J Gastroenterol. 2024 Jan 01; 119(1):147-154. Epub 2023 Sep 15.
    View PubMed
  58. Yang MM, Usiskin K, Ahmad HA, Ather S, Sreih A, Canavan JB, Farraye FA, Ma C. Considerations for Colorectal Neoplasia Detection in Inflammatory Bowel Disease Clinical Trials. Dig Dis. 2024; 42 (1):12-24 Epub 2023 Sept 27
    View PubMed
  59. Bali AS, Hashash JG, Farraye FA. Response to Benson et al. Am J Gastroenterol 2024 Jan 1; 119 (1):214-215
    View PubMed
  60. Kilani Y, Alsakarneh S, Aldiabat M, Ferreira MN, Gonzalez Mosquera DA, Jaber F, Farraye FA, Hashash JG. Frailty and Inflammatory Bowel Disease: A Nationwide Assessment. Gastro Hep Adv. 2024; 3 (7):1001-1004 Epub 2024 July 14
    View PubMed
  61. Siu RK, Karime C, Hashash JG, Kinnucan J, Picco MF, Farraye FA. Improved Outcomes Associated With Teduglutide Use in Patients With Both Short Bowel Syndrome and Crohn's Disease. Crohns Colitis 360. 2024 Jan; 6(1):otae007. Epub 2024 Jan 24.
    View PubMed
  62. Darakjian AA, Bhutani M, Fairweather D, Kocsis SC, Fliess JJ, Khatib S, Weigel GJ, McCabe EJ, Balamurugan V, Perona EE, Gehin JM, Whelan ER, Jain A, Sledge H, Hodge DO, Rozen TD, Farraye FA, Soyer O, Cheung J, Grach SL, Shirey D Jr, Gajarawala S, Munipalli B, Shufelt CL, Knight DRT, Bruno KA. Similarities and differences in self-reported symptoms and comorbidities between hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders. Rheumatol Adv Pract. 2024; 8 (4):rkae134 Epub 2024 Nov 04
    View PubMed
  63. Punj M, Desai A, Hashash JG, Farraye FA, Castillo PR. COVID-19 breakthrough infections and sleep disorders: A population-based propensity matched analysis. Sleep Med X. 2023 Dec 15; 6:100089 Epub 2023 Oct 12
    View PubMed
  64. Motwani KK, Hashash JG, Farraye FA, Kappelman MD, Weaver KN, Zhang X, Long MD, Cross RK. Impact of Holding Immunosuppressive Therapy in Patients with Inflammatory Bowel Disease Around mRNA COVID-19 Vaccine Administration on Humoral Immune Response and Development of COVID-19 Infection. J Crohns Colitis. 2023 Nov 8; 17 (10):1681-1688
    View PubMed
  65. Kuriakose Kuzhiyanjal AJ, Nigam GB, Antoniou GA, Farraye FA, Cross RK, Limdi JK. Management of Inflammatory Bowel Disease Using E-health Technologies: A Systematic Review and Meta-Analysis. J Crohns Colitis. 2023 Nov 8; 17 (10):1596-1613
    View PubMed
  66. Smith RA, Desai A, Hashash JG, Hayney MS, Farraye FA, Caldera F. Addressing the Risks of Respiratory Syncytial Virus for Patients With Inflammatory Bowel Disease in the Era of Novel Vaccines. Inflamm Bowel Dis. 2023 Nov 2; 29 (11):1842-1845
    View PubMed
  67. Koop AH, Travers PM, Khanna S, Pardi DS, Farraye FA, Hashash JG. Fidaxomicin treatment for Clostridioides difficile infection in patients with inflammatory bowel disease. J Gastroenterol Hepatol. 2023 Nov; 38 (11):1910-1916 Epub 2023 June 19
    View PubMed
  68. Itzkowitz S, Farraye FA, Limburg PJ, Gagrat Z, Olson MC, Zella J, Kisiel JB. Assessment of Stool DNA Markers to Detect Colorectal Neoplasia in Patients with Inflammatory Bowel Disease: A Multi-site Case-control Study. J Crohns Colitis. 2023 Oct 20; 17 (9):1436-1444
    View PubMed
  69. Desai A, Deepak P, Cross RK, Murone J, Farraye FA, Ungaro RC, Kochhar GS. Effect of 2 vs 3 Doses of COVID-19 Vaccine in Patients With Inflammatory Bowel Disease: A Population-based Propensity Matched Analysis. Inflamm Bowel Dis. 2023 Oct 3; 29 (10):1563-1571
    View PubMed
  70. Caldera F, Richard L, Almasry M, Phan H, Chun K, Farraye FA, Hayney MS. Persistence of Antibodies Six Months after Three COVID-19 mRNA Vaccine Doses in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2023 Oct 3; 29 (10):1662-1666
    View PubMed
  71. Beniwal-Patel P, Waclawik G, Browning K, Urmat A, Schell TL, Smith R, Huerta A, Hipp L, Dave S, Shah N, Dillon KE, Reiter-Schreurs K, Russ RK, Mailig MA, Osman F, Farraye FA, Weiss J, Hayney MS, Caldera F. Racial, Ethnic, and Geographic Disparities in Immunization Rates Among Patients With Inflammatory Bowel Disease. Crohns Colitis 360. 2023 Oct; 5 (4):otad078 Epub 2023 Dec 14
    View PubMed
  72. Hashash JG, Mourad FH, Odah T, Farraye FA, Kroner P, Stocchi L. Ethnic Variation Trends in the Use of Ileal Pouch-Anal Anastomosis in Patients With Ulcerative Colitis. Crohns Colitis 360. 2023 Oct; 5 (4):otad072 Epub 2023 Nov 16
    View PubMed
  73. Loeb L, Nasir A, Picco MF, Hashash JG, Kinnucan JA, Farraye FA. Prior Authorization of Biologics in the Management of Inflammatory Bowel Disease. Inflamm Bowel Dis 2023 Sep 1; 29 (9):e37
    View PubMed
  74. Kochhar GS, Desai A, Farraye FA, Cross RK, El-Hachem S, Dulai PS, Regueiro M. Efficacy of biologic and small molecule agents as second-line therapy after exposure to TNF inhibitors in patients with ulcerative colitis: A propensity-matched cohort study. Aliment Pharmacol Ther. 2023 Aug; 58 (3):297-308 Epub 2023 June 09
    View PubMed
  75. Caldera F, Farraye FA, Necela BM, Cogen D, Saha S, Wald A, Daoud ND, Chun K, Grimes I, Lutz M, Van Helden SR, Swift MD, Virk A, Bharucha AE, Patel TC, Gores GJ, Chumsri S, Hayney MS, Knutson KL. Higher Cell-Mediated Immune Responses in Patients With Inflammatory Bowel Disease on Anti-TNF Therapy After COVID-19 Vaccination. Inflamm Bowel Dis. 2023 Aug 1; 29 (8):1202-1209
    View PubMed
  76. Gaidos JKJ, Al Bawardy B, Farraye FA, Regueiro M. Use of Standardized Inflammatory Bowel Disease Endoscopy Scores in Clinical Practice. Crohns Colitis 360. 2023 Jul; 5 (3):otad037 Epub 2023 July 14
    View PubMed
  77. Singer D, Thompson-Leduc P, Gupta D, Poston S, Cheng WY, Ma S, Pawlowski JE, Duh MS, Devine F, Banatwala A, Bernstein E, Farraye FA. Economic and Clinical Burden of Herpes Zoster Among Patients With Inflammatory Bowel Disease in the United States. Crohns Colitis 360. 2023 Jul; 5 (3):otad033 Epub 2023 July 13
    View PubMed
  78. Patel J, Noureldin M, Fakhouri D, Farraye FA, Kovar-Gough I, Warren B, Waljee AK, Piper MS. Interventions Increase Vaccination Rates in Inflammatory Bowel Disease and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis. Dig Dis Sci. 2023 Jul; 68 (7):2921-2935 Epub 2023 Apr 06
    View PubMed
  79. Bali AS, Hashash JG, Picco MF, Kinnucan JA, Farraye FA. Electronic Health Record Burden Among Gastroenterology Providers Associated With Subspecialty and Training. Am J Gastroenterol. 2023 Jul 1; 118 (7):1282-1284 Epub 2023 Mar 20
    View PubMed
  80. Desai A, Hashash JG, Kochhar GS, Farraye FA. Tixagevimab and Cilgavimab (Evusheld) as Pre-exposure Prophylaxis for COVID-19 in Patients With Inflammatory Bowel Disease: A Propensity Matched Cohort Study. Crohns Colitis 360. 2023 Jul; 5 (3):otad047 Epub 2023 Sept 06
    View PubMed
  81. Chase RC, Tamim H, Sheikh WGE, Clift K, Bruining D, Ha C, Farraye FA, Hashash JG. Association of serum IgG4 and disease outcomes in patients with inflammatory bowel disease. Ann Gastroenterol. 2023 Jul-Aug; 36 (4):423-429 Epub 2023 May 29
    View PubMed
  82. Desai A, Hashash JG, Baker G, Farraye FA, Waghray N, Kochhar GS. Effect of Bariatric Surgery on Disease Outcomes in Patients with Inflammatory Bowel Disease: A US-based Propensity Matched Cohort Study. J Clin Gastroenterol. 2023 Jun 27 Epub 2023 June 27
    View PubMed
  83. Bhat S, Farraye FA, Hayney MS, Caldera F. How to Implement a Successful Vaccination Program in Outpatient Gastroenterology Practices: A Focus on Patients With Inflammatory Bowel Disease and Chronic Liver Disease. Gastroenterology. 2023 Jun; 164 (7):1047-1051 Epub 2021 Jan 15
    View PubMed
  84. Nelson AD, Fluxa D, Caldera F, Farraye FA, Hashash JG, Kroner PT. Thromboembolic Events in Hospitalized Patients with Inflammatory Bowel Disease. Dig Dis Sci. 2023 Jun; 68 (6):2597-2603 Epub 2023 Apr 07
    View PubMed
  85. Caldera F, Spaulding AC, Borah B, Moriarty J, Zhu Y, Hayney MS, Farraye FA. Cost-effectiveness of an adjuvanted recombinant zoster vaccine in adults with inflammatory bowel disease. Aliment Pharmacol Ther. 2023 Jun; 57 (11):1326-1334 Epub 2023 Mar 10
    View PubMed
  86. El Hage Chehade N, Ghoneim S, Shah S, Chahine A, Mourad FH, Francis FF, Binion DG, Farraye FA, Hashash JG. Efficacy of Fecal Microbiota Transplantation in the Treatment of Active Ulcerative Colitis: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials. Inflamm Bowel Dis. 2023 May 2; 29 (5):808-817
    View PubMed
  87. Crosby S, Schuh MJ, Becker M, Ivanov M, Caldera F, Farraye FA. New Pneumococcal Vaccines for Prevention of Invasive Pneumococcal Disease in Adult Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2023 Apr 3; 29 (4):661-664
    View PubMed
  88. Sulbaran M, Chen FK, Farraye FA, Hashash JG. A Clinical Review of Mesenteric Panniculitis. Gastroenterol Hepatol (N Y). 2023 Apr; 19 (4):211-218
    View PubMed
  89. Hashash JG, Desai A, Kochhar GS, Farraye FA. Efficacy of Paxlovid and Lagevrio for COVID-19 Infection in Patients With Inflammatory Bowel Disease: A Propensity-Matched Study. Clin Gastroenterol Hepatol. 2023 Mar; 21 (3):841-843.e4 Epub 2022 Sept 22
    View PubMed
  90. Weaver KN, Zhang X, Dai X, Chen W, Watkins R, Adler J, Dubinsky MC, Kastl A, Bousvaros A, Strople JA, Cross RK, Higgins PDR, Ungaro RC, Bewtra M, Bellaguarda E, Farraye FA, Craig R, Hernandez C, Boccieri ME, Firestine A, Chun KY, Long MD, Kappelman MD. Low Rates of Breakthrough COVID-19 Infection After SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2023 Mar 1; 29 (3):483-486
    View PubMed
  91. Kwon JY, Daoud ND, Hashash JG, Picco MF, Farraye FA. Efficacy of Hepatitis B Vaccination with a Novel Immunostimulatory Sequence Adjuvant (Heplisav-B) in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2023 Feb 1; 29 (2):254-259
    View PubMed
  92. Kalligeros M, Kroner PT, Farraye FA, Desalermos A. Outcomes of endoscopic retrograde cholangiopancreatography in patients with inflammatory bowel disease: a nationwide study. Int J Colorectal Dis. 2023 Jan 24; 38 (1):23
    View PubMed
  93. Lutz M, Hayney MS, Farraye FA, Caldera F. A Note on Monkeypox for Our Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis 2023 Jan 5; 29 (1):179-180
    View PubMed
  94. Sullivan KM, Farraye FA, Winthrop KL, Willer DO, Vink P, Tavares-Da-Silva F. Safety and efficacy of recombinant and live herpes zoster vaccines for prevention in at-risk adults with chronic diseases and immunocompromising conditions. Vaccine. 2023 Jan 4; 41 (1):36-48 Epub 2022 Nov 29
    View PubMed
  95. Kwon JY, Daoud N, Ghoz H, Yataco ML, Farraye FA. Efficacy of a two-dose hepatitis B vaccination with a novel immunostimulatory sequence adjuvant (Heplisav-B) on patients with chronic liver disease: a retrospective study. Transl Gastroenterol Hepatol. 2023; 8:8 Epub 2023 Jan 25
    View PubMed
  96. Kastl AJ, Weaver KN, Zhang X, Strople JA, Adler J, Dubinsky MC, Bousvaros A, Watkins R, Dai X, Chen W, Cross RK, Higgins PDR, Ungaro RC, Bewtra M, Bellaguarda EA, Farraye FA, Chun KY, Zikry M, Fernando M, Bastidas M, Hernandez CG, Craig RG, Boccieri ME, Firestine A, Long MD, Kappelman MD. Humoral Immune Response and Safety of SARS-CoV-2 Vaccination in Pediatric Inflammatory Bowel Disease. Am J Gastroenterol. 2023 Jan 1; 118 (1):129-137 Epub 2022 Sept 16
    View PubMed
  97. Singer D, Thompson-Leduc P, Gupta D, Cheng WY, Poston S, Ma S, Pawlowski JE, Duh MS, Morris ED, Devine F, Farraye FA. Incidence and risk of herpes zoster in patients with ulcerative colitis and Crohn's disease in the USA. Gastroenterol Rep (Oxf). 2023; 11:goad016 Epub 2023 Apr 12
    View PubMed
  98. Chen B, Collen LV, Mowat C, Isaacs KL, Singh S, Kane SV, Farraye FA, Snapper S, Jneid H, Lavie CJ, Krittanawong C. Inflammatory Bowel Disease and Cardiovascular Diseases. Am J Med. 2022 Dec; 135 (12):1453-1460 Epub 2022 Sept 02
    View PubMed
  99. Patil SA, Bhat S, Limdi JK, Farraye FA, Cross RK. The Sincerest Form of Flattery? Biosimilars in Inflammatory Bowel Disease. Inflamm Bowel Dis. 2022 Dec 1; 28 (12):1915-1923
    View PubMed
  100. Guerrero Vinsard D, Wakefield D, Karagozian R, Farraye FA. Herpes Zoster in Hospitalized Patients With Inflammatory Bowel Disease: National Analysis of Disease Presentation and Age Distribution. J Clin Gastroenterol. 2022 Nov 3 Epub 2022 Nov 03
    View PubMed
  101. Schell TL, Knutson KL, Saha S, Wald A, Phan HS, Almasry M, Chun K, Grimes I, Lutz M, Hayney MS, Farraye FA, Caldera F. Humoral Immunogenicity of 3 COVID-19 Messenger RNA Vaccine Doses in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2022 Nov 2; 28 (11):1781-1786
    View PubMed
  102. Fluxa D, Roussel B, Hashash JG, Farraye FA. Preventive Care and Health Maintenance in Patients with Inflammatory Bowel Disease. R I Med J (2013). 2022 Nov 1; 105 (9):8-12 Epub 2022 Nov 01
    View PubMed
  103. Hashash JG, Squire J, Francis FF, Binion DG, Cross RK, Farraye FA. An Expert Opinion/Approach: Clinical Presentations, Diagnostic Considerations, and Therapeutic Options for Gastrointestinal Manifestations of Common Variable Immune Deficiency. Am J Gastroenterol. 2022 Nov 1; 117 (11):1743-1752
    View PubMed
  104. Nelson AD, Elkins JR, Stocchi L, Farraye FA, Hashash JG. Use and Misuse of Parenteral Nutrition in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2022 Oct 3; 28 (10):1592-1602
    View PubMed
  105. Weaver KN, Zhang X, Dai X, Watkins R, Adler J, Dubinsky MC, Kastl A, Bousvaros A, Strople JA, Cross RK, Higgins PDR, Ungaro RC, Bewtra M, Bellaguarda E, Farraye FA, Boccieri ME, Firestine A, Kappelman MD, Long MD. Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID. Inflamm Bowel Dis. 2022 Oct 3; 28 (10):1497-1505
    View PubMed
  106. Kroner PT, Picco MF, Cangemi JR, Hayney MS, Farraye FA, Caldera F. The Burden of Vaccine-preventable Diseases in Patients With Inflammatory Bowel Disease. J Clin Gastroenterol. 2022 Oct 1; 56 (9):798-804 Epub 2022 Feb 14
    View PubMed
  107. Farraye FA. Vaccination Updates for Patients With Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2022 Sep; 18 (9):538-541
    View PubMed
  108. Kiran RP, Kochhar GS, Kariv R, Rex DK, Sugita A, Rubin DT, Navaneethan U, Hull TL, Ko HM, Liu X, Kachnic LA, Strong S, Iacucci M, Bemelman W, Fleshner P, Safyan RA, Kotze PG, D'Hoore A, Faiz O, Lo S, Ashburn JH, Spinelli A, Bernstein CN, Kane SV, Cross RK, Schairer J, McCormick JT, Farraye FA, Chang S, Scherl EJ, Schwartz DA, Bruining DH, Philpott J, Bentley-Hibbert S, Tarabar D, El-Hachem S, Sandborn WJ, Silverberg MS, Pardi DS, Church JM, Shen B. Management of pouch neoplasia: consensus guidelines from the International Ileal Pouch Consortium. Lancet Gastroenterol Hepatol. 2022 Sep; 7(9):871-893. Epub 2022 Jul 05.
    View PubMed
  109. Desalermos A, Pimienta M, Kalligeros M, Shehadeh F, Diamantopoulos L, Karamanolis G, Caldera F, Farraye FA. Safety of Immunizations for the Adult Patient With Inflammatory Bowel Disease-A Systematic Review and Meta-analysis. Inflamm Bowel Dis. 2022 Sep 1; 28 (9):1430-1442
    View PubMed
  110. Saade MC, Wehbe H, Mourad FH, Hosni M, Francis FF, Makki M, Binion DG, Tamim H, Farraye FA, Malik T, Hashash JG. Significance of granulomas in the outcomes of Crohn's disease patients. Ann Gastroenterol. 2022 Sep-Oct; 35 (5):503-508 Epub 2022 July 11
    View PubMed
  111. Moktan VP, Daoud ND, Tremaine WJ, Loftus EV Jr, Kane SV, Hochwald AP, Hodge DO, Hashash JG, Faubion SS, Farraye FA. A Cohort Study of the Age at Menopause in Female Patients With and Without Inflammatory Bowel Disease. Crohns Colitis 360. 2022 Jul; 4 (3):otac027 Epub 2022 Aug 04
    View PubMed
  112. Cohen BL, Fleshner P, Kane SV, Herfarth HH, Palekar N, Farraye FA, Leighton JA, Katz JA, Cohen RD, Gerich ME, Cross RK, Higgins PDR, Tinsley A, Glover S, Siegel CA, Bohl JL, Iskandar H, Ji J, Hu L, Sands BE. Prospective Cohort Study to Investigate the Safety of Preoperative Tumor Necrosis Factor Inhibitor Exposure in Patients With Inflammatory Bowel Disease Undergoing Intra-abdominal Surgery. Gastroenterology. 2022 Jul; 163 (1):204-221 Epub 2022 Apr 10
    View PubMed
  113. Rangel Paniz G, Lebow J, Sim L, Lacy BE, Farraye FA, Werlang ME. Eating Disorders: Diagnosis and Management Considerations for the IBD Practice. Inflamm Bowel Dis. 2022 Jun 3; 28 (6):936-946
    View PubMed
  114. Hashash JG, Farraye FA. Health Care Maintenance in Patients with Crohn's Disease. Gastroenterol Clin North Am. 2022 Jun; 51 (2):441-455 Epub 2022 Apr 27
    View PubMed
  115. Daoud ND, Hashash JG, Picco MF, Farraye FA. Faecal Calprotectin from Ileostomy Output Is Sensitive and Specific for the Prediction of Small Bowel Inflammation in Patients with Crohn's Disease. J Crohns Colitis. 2022 May 10; 16 (4):601-605
    View PubMed
  116. Fredrick TW, Ramos GP, Braga Neto MB, Kane S, Faubion WA, Loftus EV Jr, Pardi DS, Pasha SF, Farraye FA, Zhang L, Raffals LE. Clinical Course and Impact of Immune Checkpoint Inhibitor Colitis Resembling Microscopic Colitis. Crohns Colitis 360. 2022 Apr; 4 (2):otac008 Epub 2022 Mar 15
    View PubMed
  117. Kappelman MD, Weaver KN, Zhang X, Dai X, Watkins R, Adler J, Dubinsky MC, Kastl A, Bousvaros A, Strople JA, Cross RK, Higgins PDR, Ungaro RC, Bewtra M, Bellaguarda EA, Farraye FA, Boccieri ME, Firestine A, Chun KY, Fernando M, Bastidas M, Zikry M, Long MD. Factors Affecting Initial Humoral Immune Response to SARS-CoV-2 Vaccines Among Patients With Inflammatory Bowel Diseases. Am J Gastroenterol. 2022 Mar 1; 117 (3):462-469
    View PubMed
  118. Kwon J, Fluxá D, Fluxa D, Farraye FA, Kroner PT. Cytomegalovirus-related colitis in patients with inflammatory bowel disease. Int J Colorectal Dis. 2022 Mar; 37 (3):685-691 Epub 2022 Feb 07
    View PubMed
  119. Kroner PT, Merchea A, Colibaseanu D, Picco MF, Farraye FA, Stocchi L. The use of ileal pouch-anal anastomosis in patients with ulcerative colitis from 2009 to 2018. Colorectal Dis. 2022 Mar; 24 (3):308-313 Epub 2021 Dec 02
    View PubMed
  120. Click B, Merchea A, Colibaseanu DT, Regueiro M, Farraye FA, Stocchi L. Ileocolic Resection for Crohn Disease: The Influence of Different Surgical Techniques on Perioperative Outcomes, Recurrence Rates, and Endoscopic Surveillance. Inflamm Bowel Dis. 2022 Feb 1; 28 (2):289-298
    View PubMed
  121. Montenegro ML, Corral JE, Lukens FJ, Ji B, Kroner PT, Farraye FA, Bi Y. Pancreatic Disorders in Patients with Inflammatory Bowel Disease. Dig Dis Sci. 2022 Feb; 67 (2):423-436 Epub 2021 Feb 24
    View PubMed
  122. Cortes P, Corral JE, Umar S, Bilal M, Brahmbhatt B, Farraye FA, Kroner PT. Splenic injury is an under-recognized adverse event of in-patient colonoscopy: a nationwide analysis. Endosc Int Open. 2022 Feb; 10 (2):E178-E182 Epub 2022 Feb 15
    View PubMed
  123. Caldera F, Wald A, Saha S, Smith R, McCrone S, Farraye FA, Hayney MS. Equivalent Cellular and Humoral Immunity to Varicella Zoster Virus in Patients With Inflammatory Bowel Disease and Healthy Older Adults for Whom Immunization Is Recommended. Clin Transl Gastroenterol. 2022 Jan 19; 13 (1):e00446
    View PubMed
  124. Duly K, Farraye FA, Bhat S. COVID-19 vaccine use in immunocompromised patients: A commentary on evidence and recommendations. Am J Health Syst Pharm. 2022 Jan 5; 79 (2):63-71
    View PubMed
  125. Daoud ND, Ghoz H, Cannon R, Farraye JA, Picco MF, Kane SV, Kochhar GS, Woodhams EJ, Farraye FA. Oral Contraceptive Pills Are an Effective Method of Preventing Pregnancy in Women With Crohn's Disease. Crohns Colitis 360. 2022 Jan; 4 (1):otab078 Epub 2021 Nov 13
    View PubMed
  126. Hadi Y, Dulai PS, Kupec J, Mohy-Ud-Din N, Jairath V, Farraye FA, Kochhar GS. Incidence, outcomes, and impact of COVID-19 on inflammatory bowel disease: propensity matched research network analysis. Aliment Pharmacol Ther. 2022 Jan; 55 (2):191-200 Epub 2021 Dec 14
    View PubMed
  127. Shen B, Kochhar GS, Rubin DT, Kane SV, Navaneethan U, Bernstein CN, Cross RK, Sugita A, Schairer J, Kiran RP, Fleshner P, McCormick JT, D'Hoore A, Shah SA, Farraye FA, Kariv R, Liu X, Rosh J, Chang S, Scherl E, Schwartz DA, Kotze PG, Bruining DH, Philpott J, Abraham B, Segal J, Sedano R, Kayal M, Bentley-Hibbert S, Tarabar D, El-Hachem S, Sehgal P, Picoraro JA, Vermeire S, Sandborn WJ, Silverberg MS, Pardi DS. Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch Consortium. Lancet Gastroenterol Hepatol. 2022 Jan; 7 (1):69-95 Epub 2021 Nov 10
    View PubMed
  128. Caldera F, Knutson KL, Saha S, Wald A, Phan HS, Chun K, Grimes I, Lutz M, Hayney MS, Farraye FA. Humoral Immunogenicity of mRNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease and Healthy Controls. Am J Gastroenterol. 2022 Jan 1; 117 (1):176-179
    View PubMed
  129. Paulsen MR, Patel NR, Sulis C, Farraye FA, Bhat S. Human Papillomavirus, Herpes Zoster, and Hepatitis B Vaccinations in Immunocompromised Patients: An Update for Pharmacists. J Pharm Pract. 2021 Dec; 34 (6):943-951 Epub 2020 Sept 17
    View PubMed
  130. Fluxa D, Karime C, Wang J, Brahmbhatt B, Lukens F, Stark M, Picco M, Hashash J, Farraye F. P032 Clinical Usefulness of Double Balloon Enteroscopy in Patients With Established or Suspected Small Bowel Crohn's Disease. Am J Gastroenterol. 2021 Dec 1; 116 (Suppl 1):S8
    View PubMed
  131. Robelin K, Senada P, Ghoz H, Sim L, Lebow J, Picco M, Cangemi J, Farraye FA, Werlang M. Prevalence and Clinician Recognition of Avoidant/Restrictive Food Intake Disorder in Patients With Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2021 Nov; 17 (11):510-514
    View PubMed
  132. Cho JM, Loftus EV Jr, Bruining DH, Chedid VG, Farraye FA, Faubion WA Jr, Johnson AM, Kane SV, Kisiel JB, Malik TA, Papadakis KA, Pardi DS, Picco MF, Raffals LE, Schroeder KW, Tremaine WJ, Coelho-Prabhu N. Vulvar Crohn's Disease: Clinical Features and Outcomes. Am J Gastroenterol. 2021 Nov 1; 116 (11):2296-2299
    View PubMed
  133. Caldera F, Balzora S, Hayney MS, Farraye FA, Cross RK. Ensuring High and Equitable COVID-19 Vaccine Uptake Among Patients With IBD. Inflamm Bowel Dis. 2021 Oct 18; 27 (10):1703-1705
    View PubMed
  134. Kochhar GS, Mohan BP, Khan SR, Chandan S, Kassab LL, Ponnada S, Desai A, Caldera F, Dulai PS, Farraye FA. Hepatitis-B Vaccine Response in Inflammatory Bowel Disease Patients: A Systematic Review and Meta-analysis. Inflamm Bowel Dis. 2021 Oct 18; 27 (10):1610-1619
    View PubMed
  135. Shen B, Kochhar GS, Kariv R, Liu X, Navaneethan U, Rubin DT, Cross RK, Sugita A, D'Hoore A, Schairer J, Farraye FA, Kiran RP, Fleshner P, Rosh J, Shah SA, Chang S, Scherl E, Pardi DS, Schwartz DA, Kotze PG, Bruining DH, Kane SV, Philpott J, Abraham B, Segal J, Sedano R, Kayal M, Bentley-Hibbert S, Tarabar D, El-Hachem S, Sehgal P, McCormick JT, Picoraro JA, Silverberg MS, Bernstein CN, Sandborn WJ, Vermeire S. Diagnosis and classification of ileal pouch disorders: consensus guidelines from the International Ileal Pouch Consortium. Lancet Gastroenterol Hepatol. 2021 Oct; 6 (10):826-849 Epub 2021 Aug 18
    View PubMed
  136. Bali AS, Picco MF, Hashash JG, Farraye FA, Kroner PT. Time to Flexible Sigmoidoscopy or Colonoscopy in Patients Admitted With Ulcerative Colitis Has Decreased From 2012 to 2018. Crohns Colitis 360. 2021 Oct; 3 (4):otab080 Epub 2021 Dec 05
    View PubMed
  137. Bhat S, Caldera F, Farraye FA. Standardizing shared vaccination responsibilities among specialists to improve vaccination rates of immunosuppressed patients. Vaccine. 2021 Oct 1; 39 (41):6015-6016 Epub 2021 Sept 04
    View PubMed
  138. Bhat S, Qazi T, Farraye FA. Managing infliximab infusions after a drug holiday. Am J Health Syst Pharm 2021 Sep 7; 78 (18):1664-1665
    View PubMed
  139. Smith R, Hubers J, Farraye FA, Sampene E, Hayney MS, Caldera F. Accuracy of Self-Reported Vaccination Status in a Cohort of Patients with Inflammatory Bowel Disease. Dig Dis Sci. 2021 Sep; 66 (9):2935-2941 Epub 2020 Sept 29
    View PubMed
  140. Bhat S, Limdi JK, Cross RK, Farraye FA. Does Similarity Breed Contempt? A Review of the Use of Biosimilars in Inflammatory Bowel Disease. Dig Dis Sci. 2021 Aug; 66 (8):2513-2532 Epub 2021 June 26
    View PubMed
  141. Farraye FA, Qazi T, Kotze PG, Moore GT, Mundayat R, Lawendy N, Sharma PP, Judd DT. The impact of body mass index on efficacy and safety in the tofacitinib OCTAVE ulcerative colitis clinical programme. Aliment Pharmacol Ther. 2021 Aug; 54 (4):429-440 Epub 2021 June 24
    View PubMed
  142. Hashash JG, Francis FF, Farraye FA. Diagnosis and Management of Immune Checkpoint Inhibitor Colitis. Gastroenterol Hepatol (N Y). 2021 Aug; 17 (8):358-366
    View PubMed
  143. Squire JD, Gonzalez-Estrada A, Caldera F, Farraye FA. COVID-19 Vaccination in Patients With Inflammatory Bowel Disease and History of Reaction to Injectable Therapies. Inflamm Bowel Dis. 2021 Jul 27; 27 (8):1358-1360
    View PubMed
  144. Bhat S, Caldera F, Farraye FA. Barriers to Administering Vaccines in Inflammatory Bowel Disease Centers. Inflamm Bowel Dis. 2021 Jul 27; 27 (8):1356-1357
    View PubMed
  145. Kochhar GS, Desai A, Caldera DO F, El Hachem S, Aoun E, Sandhu D, Mohan BP, Dulai PS, Farraye FA. Effectiveness of recombinant zoster vaccine (RZV) in patients with inflammatory bowel disease. Vaccine. 2021 Jul 5; 39 (30):4199-4202 Epub 2021 June 16
    View PubMed
  146. Chen Y, Yu Q, Farraye FA, Kochhar GS, Bernstein CN, Navaneethan U, Wu K, Zhong J, Schwartz DA, Wu H, Zheng JJ, Iacucci M, Kiran RP, Shen B. Patterns of endoscopy during COVID-19 pandemic: a global survey of interventional inflammatory bowel disease practice. Intest Res. 2021 Jul; 19 (3):332-340 Epub 2020 June 02
    View PubMed
  147. Moktan VP, Koop AH, Olson MT, Lewis MD, Gomez V, Farraye FA. An Unusual Cause of Large Bowel Obstruction in a Patient With Ulcerative Colitis. ACG Case Rep J. 2021 Jul; 8 (7):e00638 Epub 2021 July 20
    View PubMed
  148. Limdi JK, Farraye FA. The Great Debate With IBD Biosimilars: Pro: Biosimilars Should Be Routinely Used as a First Line Biologic and May Be Switched From Reference Biologics. Crohns Colitis 360. 2021 Jul; 3 (3):otab015 Epub 2021 Apr 15
    View PubMed
  149. Zaver HB, Ghoz H, Azar A, Alexander LF, Toskich B, Edgar MA, Krishna M, Colibaseanu DT, Brahmbhatt B, Farraye FA. Inferior Mesenteric Arteriovenous Malformation Masquerading as Ulcerative Colitis. Am J Gastroenterol. 2021 Jun 1; 116 (6):1114
    View PubMed
  150. Shen B, Kochhar GS, Navaneethan U, Cross RK, Farraye FA, Iacucci M, Schwartz DA, Gonzalez-Lama Y, Schairer J, Kiran RP, Kotze PG, Kobayashi T, Bortlik M, Liu X, Levy AN, Gonzalez Suarez B, Tang SJ, Coelho-Prabhu N, Lukas M, Bruining DH, El-Hachem S, Charles RJ, Chen Y, Sood A, Mao R, Loras C, Dulai PS, Picoraro JA, Chiorean M, Lukas M, Shergill A, Silverberg MS, Sandborn WJ, Bernstein CN. Endoscopic evaluation of surgically altered bowel in inflammatory bowel disease: a consensus guideline from the Global Interventional Inflammatory Bowel Disease Group. Lancet Gastroenterol Hepatol. 2021 Jun; 6 (6):482-497 Epub 2021 Apr 17
    View PubMed
  151. Crosby S, Schuh MJ, Farraye FA. Rechallenge with Subcutaneous Ustekinumab After Hypersensitivity Reaction to Intravenous Ustekinumab. J Crohns Colitis 2021 May 4; 15 (5):871
    View PubMed
  152. Chugh R, Kroner PT, Farraye FA, Ginsburg PM. Small-Bowel Lymphoma Mimicking Crohn Disease: A Case Series. Inflamm Bowel Dis. 2021 Apr 15; 27 (5):e61-e62
    View PubMed
  153. Bhat S, Farraye FA, Moss A. Roles of Clinical Pharmacists in Caring for Patients With Inflammatory Bowel Disease During COVID-19. Gastroenterology 2021 Apr; 160 (5):1880 Epub 2020 May 18
    View PubMed
  154. Rolak S, Hayney MS, Farraye FA, Temte JL, Caldera F. What Gastroenterologists Should Know About COVID-19 Vaccines. Clin Gastroenterol Hepatol. 2021 Apr; 19 (4):657-661 Epub 2021 Feb 03
    View PubMed
  155. Kroner PT, Lee A, Farraye FA. Respiratory Tract Manifestations of Inflammatory Bowel Disease. Inflamm Bowel Dis. 2021 Mar 15; 27 (4):563-574
    View PubMed
  156. Moktan V, Jonica E, Li Z, Hata DJ, Farraye FA. C. difficile and the Patient with Inflammatory Bowel Disease: A Testing Dilemma. Dig Dis Sci 2021 Mar; 66 (3):921-922
    View PubMed
  157. Qazi T, Smith A, Alexander M, Hammer D, Wu T, Auerbach S, Noronha A, Wasan S, Jones E, Weinberg J, Farraye FA. Disparities in Objective Sleep Quality as Assessed Through Wrist Actigraphy in Minority Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2021 Feb 16; 27 (3):371-378
    View PubMed
  158. Caldera F, Ley D, Hayney MS, Farraye FA. Optimizing Immunization Strategies in Patients with IBD. Inflamm Bowel Dis. 2021 Jan 1; 27 (1):123-133
    View PubMed
  159. Crosby S, Schuh MJ, Caldera F, Farraye FA. Vaccination of Patients With Inflammatory Bowel Disease During the COVID-19 Pandemic. Gastroenterol Hepatol (N Y). 2021 Jan; 17 (1):18-30
    View PubMed
  160. Corral JE, Kwon JY, Caldera F, Pungpapong S, Spaulding AC, Borah BJ, Moriarty JP, Farraye FA. Cost-Effectiveness of an Adjuvanted Hepatitis B Vaccine (HEPLISAV-B) in Patients With Inflammatory Bowel Disease. Crohns Colitis 360. 2021 Jan; 3 (1):otaa090 Epub 2020 Nov 07
    View PubMed
  161. Hashash JG, Picco MF, Farraye FA. Health Maintenance for Adult Patients with Inflammatory Bowel Disease. Curr Treat Options Gastroenterol. 2021; 19 (4):583-596 Epub 2021 Nov 22
    View PubMed
  162. Ikezu T, Koro L, Wolozin B, Farraye FA, Strongosky AJ, Wszolek ZK. Crohn's and Parkinson's Disease-Associated LRRK2 Mutations Alter Type II Interferon Responses in Human CD14(+) Blood Monocytes Ex Vivo. J Neuroimmune Pharmacol. 2020 Dec; 15 (4):794-800 Epub 2020 Mar 16
    View PubMed
  163. Lutz M, Hayney MS, Farraye FA, Caldera F. Reducing the Risk of Vaccine Preventable Diseases During the COVID-19 Pandemic. Clin Gastroenterol Hepatol. 2020 Dec; 18 (13):2868-2872 Epub 2020 Sept 24
    View PubMed
  164. Green ME, Brahmbhatt B, Baumgarten D, Krishna M, Stocchi L, Farraye FA. Meckel's Diverticulum Masquerading as Crohn Disease. Inflamm Bowel Dis 2020 Oct 23; 26 (11):e150-e151
    View PubMed
  165. Satyam VR, Li PH, Reich J, Qazi T, Noronha A, Wasan SK, Farraye FA. Safety of Recombinant Zoster Vaccine in Patients with Inflammatory Bowel Disease. Dig Dis Sci. 2020 Oct; 65 (10):2986-2991 Epub 2020 Jan 02
    View PubMed
  166. Bhat S, Farraye FA, Moss AC. Impact of Clinical Pharmacists in Inflammatory Bowel Disease Centers During the COVID-19 Pandemic. Am J Gastroenterol. 2020 Sep; 115 (9):1532-1533
    View PubMed
  167. Corral JE, Hoogenboom SA, Kroner PT, Vazquez-Roque MI, Picco MF, Farraye FA, Wallace MB. COVID-19 polymerase chain reaction testing before endoscopy: an economic analysis. Gastrointest Endosc. 2020 Sep; 92 (3):524-534.e6 Epub 2020 Apr 28
    View PubMed
  168. Caldera F, Hayney MS, Farraye FA. Vaccination in Patients With Inflammatory Bowel Disease. Am J Gastroenterol. 2020 Sep; 115 (9):1356-1361
    View PubMed
  169. Chen Y, Hu S, Wu H, Farraye FA, Bernstein CN, Zheng JJ, Kiran RP, Shen B. Patterns of care for inflammatory bowel disease in China during the COVID-19 pandemic. Lancet Gastroenterol Hepatol. 2020 Jul; 5 (7):632-634 Epub 2020 May 13
    View PubMed
  170. Guo L, Rohde J, Farraye FA. Stigma and Disclosure in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2020 Jun 18; 26 (7):1010-1016
    View PubMed
  171. Grossberg LB, Farraye FA, Papamichael K, Cheifetz AS, Feuerstein JD. A Survey Study of Gastroenterologists' Views on Dysplasia Surveillance and Chromoendoscopy in IBD. Inflamm Bowel Dis 2020 Jun 18; 26 (7):e59-e61
    View PubMed
  172. Shen B, Kochhar G, Navaneethan U, Farraye FA, Schwartz DA, Iacucci M, Bernstein CN, Dryden G, Cross R, Bruining DH, Kobayashi T, Lukas M, Shergill A, Bortlik M, Lan N, Lukas M, Tang SJ, Kotze PG, Kiran RP, Dulai PS, El-Hachem S, Coelho-Prabhu N, Thakkar S, Mao R, Chen G, Zhang S, Suarez BG, Lama YG, Silverberg MS, Sandborn WJ. Practical guidelines on endoscopic treatment for Crohn's disease strictures: a consensus statement from the Global Interventional Inflammatory Bowel Disease Group. Lancet Gastroenterol Hepatol. 2020 Apr; 5 (4):393-405 Epub 2020 Jan 16
    View PubMed
  173. Limdi JK, Picco M, Farraye FA. A review of endoscopic scoring systems and their importance in a treat-to-target approach in inflammatory bowel disease (with videos). Gastrointest Endosc. 2020 Apr; 91 (4):733-745 Epub 2019 Nov 29
    View PubMed
  174. Bhat S, Altajar S, Shankar D, Zahorian T, Robert R, Qazi T, Shah B, Farraye FA. Process and Clinical Outcomes of a Biosimilar Adoption Program with Infliximab-Dyyb. J Manag Care Spec Pharm. 2020 Apr; 26 (4):410-416
    View PubMed
  175. Kroner PT, Mody K, Farraye FA. Immune checkpoint inhibitor-related luminal GI adverse events. Gastrointest Endosc. 2019 Dec; 90 (6):881-892 Epub 2019 Sept 14
    View PubMed
  176. Qazi T, Farraye FA. Sleep Disturbances in the Elderly Patient with Inflammatory Bowel Disease. Curr Treat Options Gastroenterol. 2019 Dec; 17 (4):470-491
    View PubMed
  177. Qazi T, Christian KE, Farraye FA, Cross RC. Pericardial Manifestations in Inflammatory Bowel Disease: A Report of Two Cases Crohn's & Colitis 360. October 2019; 1(3).
  178. Jonica ER, Sulis CA, Soni K, Hughes M, Jones E, Weinberg J, Miller NS, Farraye FA. Role of Cycle Threshold in Clostridioides difficile Polymerase Chain Reaction Testing as a Predictor of Clinical Outcomes in Patients With Inflammatory Bowel Disease Crohn's & Colitis 360. October 2019; 1(3).
  179. Reich J, Canakis A, Shankar D, Harrington J, Apte M, Weinberg J, Jones E, Noronha A, Wasan SK, Farraye FA. The Use of An EHR Patient Portal (Mychart-Epic) in Patients With Inflammatory Bowel Disease Crohn's & Colitis 360. October 2019; 1(3).
  180. Feuerstein JD, Moss AC, Farraye FA. Ulcerative colitis (vol 94, pg 1357, 2019) Mayo Clinic Proceedings. 2019 Oct; 94 (10):2149
  181. Bhat S, Lee S, Bernstein DE, Farraye FA. Conquering the Prior Authorization Maze ACG Magazine. 2019.
  182. Picco MF, Farraye FA. Targeting Mucosal Healing in Crohn's Disease. Gastroenterol Hepatol (N Y). 2019 Oct; 15 (10):529-538
    View PubMed
  183. Caldera F, Farraye FA, Rosh JR, Hayney MS. Prudence Using Serology to Determine Vaccine-Induced Immunity to Measles and Varicella in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis 2019 Aug 20; 25 (9):e113
    View PubMed
  184. Feuerstein JD, Moss AC, Farraye FA. Ulcerative Colitis. Mayo Clin Proc. 2019 Jul; 94 (7):1357-1373
    View PubMed
  185. Boden EK, Canavan JB, Moran CJ, McCann K, Dunn WA, Farraye FA, Ananthakrishnan AN, Yajnik V, Gandhi R, Nguyen DD, Bhan AK, Weiner HL, Korzenik JR, Snapper SB. Immunologic Alterations Associated With Oral Delivery of Anti-CD3 (OKT3) Monoclonal Antibodies in Patients With Moderate-to-Severe Ulcerative Colitis. Crohns Colitis 360. 2019 Jul; 1 (2):otz009 Epub 2019 June 07
    View PubMed
  186. Limdi JK, Farraye J, Cannon R, Woodhams E, Farraye FA. Contraception, Venous Thromboembolism, and Inflammatory Bowel Disease: What Clinicians (and Patients) Should Know. Inflamm Bowel Dis. 2019 Mar 16 [Epub ahead of print]
    View PubMed
  187. Zullow S, Farraye FA. Updates on vaccinating the inflammatory bowel disease patient. Expert Rev Gastroenterol Hepatol. 2019 Mar; 13 (3):229-239 Epub 2019 Jan 21
    View PubMed
  188. Apte M, Reich J, Zahorian T, Farraye FA. Improving Vaccination Rates for IBD Patients Through the Use of Local Pharmacies. Inflamm Bowel Dis. 2019 Feb 21; 25 (3):e19
    View PubMed
  189. Reich J, Guo L, Groshek J, Weinberg J, Chen W, Martin C, Long MD, Farraye FA. Social Media Use and Preferences in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2019 Feb 21; 25 (3):587-591
    View PubMed
  190. Bhat S, Zahorian T, Robert R, Farraye FA. Advocating for Patients With Inflammatory Bowel Disease: How to Navigate the Prior Authorization Process. Inflamm Bowel Dis. 2019 Feb 8 Epub 2019 Feb 08
    View PubMed
  191. Shen B, Kochhar G, Navaneethan U, Liu X, Farraye FA, Gonzalez-Lama Y, Bruining D, Pardi DS, Lukas M, Bortlik M, Wu K, Sood A, Schwartz DA, Sandborn WJ, Global Interventional Inflammatory Bowel Disease Group. Role of interventional inflammatory bowel disease in the era of biologic therapy: a position statement from the Global Interventional IBD Group. Gastrointest Endosc. 2019 Feb; 89 (2):215-237 Epub 2018 Oct 24
    View PubMed
  192. Tormey LK, Reich J, Chen YS, Singh A, Lipkin-Moore Z, Yu A, Weinberg J, Farraye FA, Paasche-Orlow MK. Limited Health Literacy Is Associated With Worse Patient-Reported Outcomes in Inflammatory Bowel Disease. Inflamm Bowel Dis. 2019 Jan 1; 25 (1):204-212
    View PubMed
  193. Coukos J, Farraye FA. Update on Vaccinating the Patient With Inflammatory Bowel Disease. Curr Treat Options Gastroenterol. 2018 Dec; 16 (4):548-560
    View PubMed
  194. Chudy-Onwugaje KO, Christian KE, Farraye FA, Cross RK. A State-of-the-Art Review of New and Emerging Therapies for the Treatment of IBD. Inflamm Bowel Dis. 2018 Nov 15 [Epub ahead of print]
    View PubMed
  195. Qazi T, Farraye FA. Sleep and Inflammatory Bowel Disease: An Important Bi-Directional Relationship. Inflamm Bowel Dis. 2018 Nov 2 Epub 2018 Nov 02
    View PubMed
  196. Shergil A, Odze RD, Farraye FA. Surveillance and management of dysplasia in patients with inflammatory bowel disease. Up to Date. 2018 May.
  197. Limdi JK, Farraye FA. An Update on Surveillance in Ulcerative Colitis. Curr Gastroenterol Rep. 2018 Mar 7; 20 (2):7 Epub 2018 Mar 07
    View PubMed
  198. Pratt PK Jr, David N, Weber HC, Little FF, Kourkoumpetis T, Patts GJ, Weinberg J, Farraye FA. Antibody Response to Hepatitis B Virus Vaccine is Impaired in Patients With Inflammatory Bowel Disease on Infliximab Therapy. Inflamm Bowel Dis. 2018 Jan 18; 24 (2):380-386
    View PubMed
  199. Rohde JA, Wang Y, Cutino CM, Dickson BK, Bernal MC, Bronda S, Liu A, Priyadarshini SI, Guo L, Reich JS, Farraye FA. Impact of Disease Disclosure on Stigma: An Experimental Investigation of College Students' Reactions to Inflammatory Bowel Disease. J Health Commun. 2018; 23 (1):91-97 Epub 2017 Dec 28
    View PubMed
  200. Mammen A, Farraye F, Liang Y, Shin H, Harnett W, Harnett M, Nikolajczyk B, Ganley-Leal L. The interplay between human b cells, eosinophils and helminths: a novel aspect of the hygiene hypothesis. American Journal of Tropical Medicine and Hygiene. 2008; 79(6):337-38.
  201. Groshek J, Basil M, Guo L, Parker Ward S, Farraye FA, Reich J. Media Consumption and Creation in Attitudes Toward and Knowledge of Inflammatory Bowel Disease: Web-Based Survey. J Med Internet Res. 2017 Dec 8; 19 (12):e403 Epub 2017 Dec 08
    View PubMed
  202. Fine S, Nee J, Thakuria P, Duff B, Farraye FA, Shah SA. Ocular, Auricular, and Oral Manifestations of Inflammatory Bowel Disease. Dig Dis Sci. 2017 Dec; 62 (12):3269-3279 Epub 2017 Oct 24
    View PubMed
  203. Reich J, Wasan SK, Farraye FA. Vaccination and Health Maintenance Issues to Consider in Patients With Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2017 Dec; 13 (12):717-724
    View PubMed
  204. Iskandar H, Greer JB, Krasinskas AM, Tinsley AT, Koltun WA, Siegel CA, Levy LC, Herfarth HH, Farraye FA, Binion DG, Rosh JR, Keljo DJ, Isaacs KL, Regueiro MD. IBD LIVE Series-Case 8: Treatment Options for Refractory Esophageal Crohn's Disease and Hidradenitis Suppurativa. Inflamm Bowel Dis. 2017 Oct; 23 (10):1667-1677
    View PubMed
  205. Kochar B, Long MD, Shelton E, Young L, Farraye FA, Yajnik V, Herfarth H. Safety and Efficacy of Teduglutide (Gattex) in Patients With Crohn's Disease and Need for Parenteral Support Due to Short Bowel Syndrome-associated Intestinal Failure. J Clin Gastroenterol. 2017 Jul; 51 (6):508-511
    View PubMed
  206. Farraye FA, Melmed GY, Lichtenstein GR, Kane SV. Corrigendum: ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease. Am J Gastroenterol. 2017 Jul; 112 (7):1208 Epub 2017 May 23
    View PubMed
  207. Farraye FA. Vaccination of Patients With Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2017 Jul; 13 (7):431-434
    View PubMed
  208. Thompson CC, Abu Dayyeh BK, Kushner R, Sullivan S, Schorr AB, Amaro A, Apovian CM, Fullum T, Zarrinpar A, Jensen MD, Stein AC, Edmundowicz S, Kahaleh M, Ryou M, Bohning JM, Ginsberg G, Huang C, Tran DD, Glaser JP, Martin JA, Jaffe DL, Farraye FA, Ho SB, Kumar N, Harakal D, Young M, Thomas CE, Shukla AP, Ryan MB, Haas M, Goldsmith H, McCrea J, Aronne LJ. Percutaneous Gastrostomy Device for the Treatment of Class II and Class III Obesity: Results of a Randomized Controlled Trial. Am J Gastroenterol. 2017 Mar; 112 (3):447-457 Epub 2016 Dec 06
    View PubMed
  209. Farraye FA, Melmed GY, Lichtenstein GR, Kane SV. ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease. Am J Gastroenterol. 2017 Feb; 112 (2):241-258 Epub 2017 Jan 10
    View PubMed
  210. Kisiel JB, Konijeti GG, Piscitello AJ, Chandra T, Goss TF, Ahlquist DA, Farraye FA, Ananthakrishnan AN. Stool DNA Analysis is Cost-Effective for Colorectal Cancer Surveillance in Patients With Ulcerative Colitis. Clin Gastroenterol Hepatol. 2016 Dec; 14 (12):1778-1787.e8 Epub 2016 July 25
    View PubMed
  211. Reich J, Guo L, Hall J, Tran A, Weinberg J, Groshek J, Rowell TE, DiPalma JA, Farraye FA. A Survey of Social Media Use and Preferences in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2016 Nov; 22 (11):2678-2687
    View PubMed
  212. Rajan D, Greer JB, Regueiro MD, Baidoo L, Binion DG, Herfarth HH, Siegel CA, Hartman DJ, Farraye FA, Koutroubakis IE, Brand MH, Williams ED, Goyal A, Cross RK. IBD LIVE Case Series-Case 6. Inflamm Bowel Dis. 2016 Nov; 22 (11):2754-2764
    View PubMed
  213. Abdat R, Markova A, Farraye FA, Lichtman MK. Ustekinumab for treatment of cutaneous Crohn's disease. Dermatol Online J. 2016 Oct 15; 22 (10)
    View PubMed
  214. Anastassopoulos K, Farraye FA, Knight T, Colman S, Cleveland MV, Pelham RW. A Comparative Study of Treatment-Emergent Adverse Events Following Use of Common Bowel Preparations Among a Colonoscopy Screening Population: Results from a Post-Marketing Observational Study. Dig Dis Sci. 2016 Oct; 61 (10):2993-3006 Epub 2016 June 09
    View PubMed
  215. Reich J, Wasan S, Farraye FA. Vaccinating Patients With Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2016 Sep; 12 (9):540-546
    View PubMed
  216. Reich JS, Farraye FA, Wasan SK. Preventative Care in the Patient with Inflammatory Bowel Disease: What Is New? Dig Dis Sci. 2016 Aug; 61 (8):2205-16 Epub 2016 Apr 09
    View PubMed
  217. Wasan SK, Zullow S, Berg A, Cheifetz AS, Ganley-Leal L, Farraye FA. Herpes Zoster Vaccine Response in Inflammatory Bowel Disease Patients on Low-dose Immunosuppression. Inflamm Bowel Dis. 2016 Jun; 22 (6):1391-6
    View PubMed
  218. Gulati A, Clarke K, Greer JB, Binion DG, Brand MH, Farraye FA, Cross RK, Baidoo L, Schraut WH, Hartman DJ, Regueiro MD. IBD LIVE Case Series-Case 4: Worms in IBD: Friend or Foe. Inflamm Bowel Dis. 2016 Jun; 22 (6):1462-72
    View PubMed
  219. Guo L, Reich J, Groshek J, Farraye FA. Social Media Use in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2016 May; 22 (5):1231-8
    View PubMed
  220. Hughes M, Qazi T, Berg A, Weinberg J, Chen X, Kelly CP, Farraye FA. Host Immune Response to Clostridium difficile Infection in Inflammatory Bowel Disease Patients. Inflamm Bowel Dis. 2016 Apr; 22 (4):853-61
    View PubMed
  221. Tormey LK, Farraye FA, Paasche-Orlow MK. Understanding Health Literacy and its Impact on Delivering Care to Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2016 Mar; 22 (3):745-51
    View PubMed
  222. Qazi T, Shah B, El-Dib M, Farraye FA. The Tolerability and Efficacy of Rapid Infliximab Infusions in Patients with Inflammatory Bowel Disease. Dig Dis Sci. 2016 Feb; 61 (2):589-96 Epub 2015 Oct 06
    View PubMed
  223. Huynh L, Yermakov S, Davis M, Campbell R, Cleveland M, Farraye FA, Yenikomshian M. Cost-analysis model of colonoscopy preparation using split-dose reduced-volume oral sulfate solution (OSS) and polyethylene glycol with electrolytes solution (PEG-ELS). J Med Econ. 2016; 19 (4):356-63 Epub 2015 Dec 21
    View PubMed
  224. Okafor PN, Farraye FA, Okafor AT, Erim DO. Cost-effectiveness of Prophylaxis Against Pneumocystis jiroveci Pneumonia in Patients with Crohn's Disease. Dig Dis Sci. 2015 Dec; 60 (12):3743-55 Epub 2015 July 16
    View PubMed
  225. Iskandar HN, Dhere T, Farraye FA. Ulcerative Colitis: Update on Medical Management. Curr Gastroenterol Rep. 2015 Nov; 17 (11):44
    View PubMed
  226. Shen J, Gibson JA, Schulte S, Khurana H, Farraye FA, Levine J, Burakoff R, Cerda S, Qazi T, Hamilton M, Srivastava A, Odze RD. Clinical, pathologic, and outcome study of hyperplastic and sessile serrated polyps in inflammatory bowel disease. Hum Pathol. 2015 Oct; 46 (10):1548-56 Epub 2015 July 08
    View PubMed
  227. Stallwood C, Shergill K, Wu J, Farraye FA, Miller HL. Manifestations of inflammatory bowel disease in patients of Haitian and Cape Verdean descent. Scand J Gastroenterol. 2015 Jul; 50 (7):832-40 Epub 2015 Feb 04
    View PubMed
  228. Stallwood C, Shergill K, Wu J, Farraye FA, Miller HL. Erratum. Scand J Gastroenterol. 2015 Jul; 50 (7):932 Epub 2015 Feb 20
    View PubMed
  229. Reich JS, Miller HL, Wasan SK, Noronha A, Ardagna E, Sullivan K, Jacobson B, Farraye FA. Influenza and Pneumococcal Vaccination Rates in Patients With Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2015 Jun; 11 (6):396-401
    View PubMed
  230. Kalman RS, Hartshorn K, Farraye FA. Does a personal or family history of malignancy preclude the use of immunomodulators and biologics in IBD. Inflamm Bowel Dis. 2015 Feb; 21 (2):428-35
    View PubMed
  231. Desalermos AP, Farraye FA, Wasan SK. Vaccinating the inflammatory bowel disease patient. Expert Rev Gastroenterol Hepatol. 2015 Jan; 9 (1):91-102 Epub 2014 Aug 27
    View PubMed
  232. Qazi TM, O'Brien MJ, Farraye FA, Gould RW, Chen CA, Schroy PC 3rd. Epidemiology of goblet cell and microvesicular hyperplastic polyps. Am J Gastroenterol. 2014 Dec; 109 (12):1922-32 Epub 2014 Oct 28
    View PubMed
  233. Friedman S, Cheifetz AS, Farraye FA, Banks PA, Makrauer FL, Burakoff R, Farmer B, Torgersen LN, Wahl KE. High self-efficacy predicts adherence to surveillance colonoscopy in inflammatory bowel disease. Inflamm Bowel Dis. 2014 Sep; 20 (9):1602-10
    View PubMed
  234. Shah SA, Rubin DT, Farraye FA. Chromoendoscopy for colorectal cancer surveillance in patients with inflammatory bowel disease. Curr Gastroenterol Rep. 2014 Sep; 16 (9):407
    View PubMed
  235. Shergill AK, Farraye FA. Toward a consensus on endoscopic surveillance of patients with colonic inflammatory bowel disease. Gastrointest Endosc Clin N Am. 2014 Jul; 24 (3):469-81 Epub 2014 May 06
    View PubMed
  236. Rodriguez-Diaz E, Atkinson C, Jepeal LI, Berg A, Huang CS, Cerda SR, O'Brien MJ, Bigio IJ, Farraye FA, Singh SK. Elastic scattering spectroscopy as an optical marker of inflammatory bowel disease activity and subtypes. Inflamm Bowel Dis. 2014 Jun; 20 (6):1029-36
    View PubMed
  237. Kwah J, Farraye FA. Current and Future Status for Evaluation of Dysplasia and Carcinoma in IBD. Curr Treat Options Gastroenterol. 2014 Mar; 12 (1):90-102
    View PubMed
  238. Wasan SK, Calderwood AH, Long MD, Kappelman MD, Sandler RS, Farraye FA. Immunization rates and vaccine beliefs among patients with inflammatory bowel disease: an opportunity for improvement. Inflamm Bowel Dis. 2014 Feb; 20 (2):246-50
    View PubMed
  239. Kalman RS, Gjede JM, Farraye FA. Pyostomatitis vegetans in a patient with fistulizing Crohn's disease. Clin Gastroenterol Hepatol. 2013 Dec; 11 (12):A24 Epub 2013 Mar 21
    View PubMed
  240. Okafor PN, Stallwood CG, Nguyen L, Sahni D, Wasan SK, Farraye FA, Erim DO. Cost-effectiveness of nonmelanoma skin cancer screening in Crohn's disease patients. Inflamm Bowel Dis. 2013 Dec; 19 (13):2787-95
    View PubMed
  241. Berg AM, Dam AN, Farraye FA. Environmental influences on the onset and clinical course of Crohn's disease-part 2: infections and medication use. Gastroenterol Hepatol (N Y). 2013 Dec; 9 (12):803-10
    View PubMed
  242. Dam AN, Berg AM, Farraye FA. Environmental influences on the onset and clinical course of Crohn's disease-part 1: an overview of external risk factors. Gastroenterol Hepatol (N Y). 2013 Nov; 9 (11):711-7
    View PubMed
  243. Agarwal S, Stucchi AF, Dendrinos K, Cerda S, O'Brien MJ, Becker JM, Heeren T, Farraye FA. Is pyloric gland metaplasia in ileal pouch biopsies a marker for Crohn's disease? Dig Dis Sci. 2013 Oct; 58 (10):2918-25 Epub 2013 Mar 30
    View PubMed
  244. Ordonez ME, Farraye FA, Di Palma JA. Endemic fungal infections in inflammatory bowel disease associated with anti-TNF antibody therapy. Inflamm Bowel Dis. 2013 Oct; 19 (11):2490-500
    View PubMed
  245. Juillerat P, Wasan SK, Fowler SA, Friedman S, Pabby VK, Coukas JA, Barto AE, Pellish R, Germansky KA, Cheifetz AS, Korzenik JR, Farraye FA, Yajnik V. Efficacy and safety of natalizumab in Crohn's disease patients treated at 6 Boston academic hospitals. Inflamm Bowel Dis. 2013 Oct; 19 (11):2457-63
    View PubMed
  246. Okafor PN, Nunes DP, Farraye FA. Pneumocystis jiroveci pneumonia in inflammatory bowel disease: when should prophylaxis be considered? Inflamm Bowel Dis. 2013 Jul; 19 (8):1764-71
    View PubMed
  247. Gillespie E, Leeman SE, Watts LA, Coukos JA, O'Brien MJ, Cerda SR, Farraye FA, Stucchi AF. Plasminogen activator inhibitor-1 is increased in colonic epithelial cells from patients with colitis-associated cancer. J Crohns Colitis. 2013 Jun; 7 (5):403-11 Epub 2012 Aug 23
    View PubMed
  248. Quinn AM, Farraye FA, Naini BV, Cerda S, Coukos J, Li Y, Khor T, Odze RD. Polypectomy is adequate treatment for adenoma-like dysplastic lesions (DALMs) in Crohn's disease. Inflamm Bowel Dis. 2013 May; 19 (6):1186-93
    View PubMed
  249. Long MD, Farraye FA, Okafor PN, Martin C, Sandler RS, Kappelman MD. Increased risk of pneumocystis jiroveci pneumonia among patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013 Apr; 19 (5):1018-24
    View PubMed
  250. Rehman MQ, Beal D, Liang Y, Noronha A, Winter H, Farraye FA, Ganley-Leal L. B cells secrete eotaxin-1 in human inflammatory bowel disease. Inflamm Bowel Dis. 2013 Apr; 19 (5):922-33
    View PubMed
  251. Bennett M, Tompkins H, Seymour B, O'Brien MJ, Farraye FA. Spontaneous colonic perforation in a patient with collagenous colitis. Gastroenterol Hepatol (N Y). 2013 Apr; 9 (4):262-4
    View PubMed
  252. Friedman S, Cheifetz AS, Farraye FA, Banks PA, Makrauer FL, Burakoff R, Farmer B, Torgersen LN, Wahl KE. Factors that affect adherence to surveillance colonoscopy in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013 Mar; 19 (3):534-9
    View PubMed
  253. Okafor PN, Wasan SK, Farraye FA. Pneumocystis jiroveci pneumonia in patients with inflammatory bowel disease: a survey of prophylaxis patterns among gastroenterology providers. Inflamm Bowel Dis. 2013 Mar-Apr; 19 (4):812-7
    View PubMed
  254. Berg AM, Kelly CP, Farraye FA. Clostridium difficile infection in the inflammatory bowel disease patient. Inflamm Bowel Dis. 2013 Jan; 19 (1):194-204
    View PubMed
  255. Manolakis CS, Farraye FA, Di Palma JA. Crohn's disease: the subsequent visit. Gastroenterol Hepatol (N Y). 2013 Jan; 9 (1):16-20
    View PubMed
  256. Friedman S, Cheifetz AS, Farraye FA, Banks PA, Makrauer FL, Burakoff R, Farmer B, Torgersen LN, Wahl KE. Doctor message can alter patients' behavior and attitudes regarding inflammatory bowel disease and colon cancer. Inflamm Bowel Dis. 2012 Aug; 18 (8):1531-9 Epub 2011 Sept 16
    View PubMed
  257. Roehrl MH, Farraye FA. Capillary hemangioma of the esophagus in a patient with systemic sclerosis and gastric antral vascular ectasia. Gastrointest Endosc. 2012 Aug; 76 (2):418-9
    View PubMed
  258. Coukos JA, Howard LA, Weinberg JM, Becker JM, Stucchi AF, Farraye FA. ASCA IgG and CBir antibodies are associated with the development of Crohn's disease and fistulae following ileal pouch-anal anastomosis. Dig Dis Sci. 2012 Jun; 57 (6):1544-53 Epub 2012 Feb 07
    View PubMed
  259. Sinclair JA, Wasan SK, Farraye FA. Health maintenance in the inflammatory bowel disease patient. Gastroenterol Clin North Am. 2012 Jun; 41 (2):325-37 Epub 2012 Feb 24
    View PubMed
  260. Humm SD, Farraye FA. "Cat scratch" colon in a female patient after a difficult screening colonoscopy. Gastroenterol Hepatol (N Y). 2012 May; 8 (5):352
    View PubMed
  261. Soucy G, Wang HH, Farraye FA, Schmidt JF, Farris AB, Lauwers GY, Cerda SR, Dendrinos KG, Odze RD. Clinical and pathological analysis of colonic Crohn's disease, including a subgroup with ulcerative colitis-like features. Mod Pathol. 2012 Feb; 25 (2):295-307 Epub 2011 Aug 12
    View PubMed
  262. Wasan SK, Coukos JA, Farraye FA. Vaccinating the inflammatory bowel disease patient: deficiencies in gastroenterologists knowledge. Inflamm Bowel Dis. 2011 Dec; 17 (12):2536-40 Epub 2011 Apr 28
    View PubMed
  263. Gillespie E, Leeman SE, Watts LA, Coukos JA, O'Brien MJ, Cerda SR, Farraye FA, Stucchi AF, Becker JM. Truncated neurokinin-1 receptor is increased in colonic epithelial cells from patients with colitis-associated cancer. Proc Natl Acad Sci U S A. 2011 Oct 18; 108 (42):17420-5 Epub 2011 Oct 03
    View PubMed
  264. Mamula P, Tierney WM, Banerjee S, Desilets D, Diehl DL, Farraye FA, Kaul V, Kethu SR, Kwon RS, Pedrosa MC, Rodriguez SA, Wong Kee Song LM, ASGE Technology Committee. Devices to improve colon polyp detection. Gastrointest Endosc. 2011 Jun; 73 (6):1092-7
    View PubMed
  265. Kakkar A, Wasan SK, Farraye FA. Targeting mucosal healing in Crohn's disease. Gastroenterol Hepatol (N Y). 2011 Jun; 7 (6):374-80
    View PubMed
  266. Song LM, Banerjee S, Desilets D, Song LM, Diehl DL, Farraye FA, Kaul V, Kethu SR, Kwon RS, Mamula P, Pedrosa MC, Rodriguez SA, Tierney WM, ASGE Technology Committee. Autofluorescence imaging. Gastrointest Endosc. 2011 Apr; 73 (4):647-50
    View PubMed
  267. Gainsbury ML, Chu DI, Howard LA, Coukos JA, Farraye FA, Stucchi AF, Becker JM. Preoperative infliximab is not associated with an increased risk of short-term postoperative complications after restorative proctocolectomy and ileal pouch-anal anastomosis. J Gastrointest Surg. 2011 Mar; 15 (3):397-403 Epub 2011 Jan 19
    View PubMed
  268. Di Palma JA, Farraye FA. Crohn's disease: the first visit. Gastroenterol Hepatol (N Y). 2011 Mar; 7 (3):163-9
    View PubMed
  269. Banerjee S, Desilets D, Diehl DL, Farraye FA, Kaul V, Kethu SR, Kwon RS, Mamula P, Pedrosa MC, Rodriguez SA, Song LM, Tierney WM, Song LM, ASGE Technology Committee. Computer-assisted personalized sedation. Gastrointest Endosc. 2011 Mar; 73 (3):423-7 Epub 2011 Jan 14
    View PubMed
  270. Huang CS, Farraye FA, Yang S, O'Brien MJ. The clinical significance of serrated polyps. Am J Gastroenterol. 2011 Feb; 106 (2):229-40; quiz 241 Epub 2010 Nov 02
    View PubMed
  271. McDonnell M, Liang Y, Noronha A, Coukos J, Kasper DL, Farraye FA, Ganley-Leal LM. Systemic Toll-like receptor ligands modify B-cell responses in human inflammatory bowel disease. Inflamm Bowel Dis. 2011 Jan; 17 (1):298-307 Epub 2010 Aug 30
    View PubMed
  272. Liang Y, Hasturk H, Elliot J, Noronha A, Liu X, Wetzler LM, Massari P, Kantarci A, Winter HS, Farraye FA, Ganley-Leal LM. Toll-like receptor 2 induces mucosal homing receptor expression and IgA production by human B cells. Clin Immunol. 2011 Jan; 138 (1):33-40 Epub 2010 Oct 14
    View PubMed
  273. Wasan SK, Skolnik PR, Farraye FA. A 24-year-old patient with Crohn's disease starting immunosuppressive therapy: vaccination issues to consider. Clin Gastroenterol Hepatol. 2010 Dec; 8 (12):1013-6 Epub 2010 July 23
    View PubMed
  274. Hetzel JT, Huang CS, Coukos JA, Omstead K, Cerda SR, Yang S, O'Brien MJ, Farraye FA. Variation in the detection of serrated polyps in an average risk colorectal cancer screening cohort. Am J Gastroenterol. 2010 Dec; 105 (12):2656-64 Epub 2010 Aug 17
    View PubMed
  275. Ganley-Leal LM, Liang Y, Jagannathan-Bogdan M, Farraye FA, Nikolajczyk BS. Differential regulation of TLR4 expression in human B cells and monocytes. Mol Immunol. 2010 Nov-Dec; 48 (1-3):82-8 Epub 2010 Oct 16
    View PubMed
  276. Kethu SR, Banerjee S, Desilets D, Diehl DL, Farraye FA, Kaul V, Kwon RS, Mamula P, Pedrosa MC, Rodriguez SA, Wong Kee Song LM, Tierney WM, ASGE Technology Committee. Endoscopic tattooing. Gastrointest Endosc. 2010 Oct; 72 (4):681-5
    View PubMed
  277. Desilets D, Kaul V, Tierney WM, Banerjee S, Diehl DL, Farraye FA, Kethu SR, Kwon RS, Mamula P, Pedrosa MC, Rodriguez SA, Wong Kee Song LM, ASGE Technology Committee. Automated endoscope reprocessors. Gastrointest Endosc. 2010 Oct; 72 (4):675-80
    View PubMed
  278. Kwon RS, Banerjee S, Desilets D, Diehl DL, Farraye FA, Kaul V, Mamula P, Pedrosa MC, Rodriguez SA, Varadarajulu S, Song LM, Tierney WM, Song LM, ASGE Technology Committee. Enteral nutrition access devices. Gastrointest Endosc. 2010 Aug; 72 (2):236-48 Epub 2010 June 11
    View PubMed
  279. Pedrosa MC, Farraye FA, Shergill AK, Banerjee S, Desilets D, Diehl DL, Kaul V, Kwon RS, Mamula P, Rodriguez SA, Varadarajulu S, Song LM, Tierney WM, Song LM, ASGE Technology Committee. Minimizing occupational hazards in endoscopy: personal protective equipment, radiation safety, and ergonomics. Gastrointest Endosc. 2010 Aug; 72 (2):227-35 Epub 2010 May 26
    View PubMed
  280. Kaul V, Adler DG, Conway JD, Farraye FA, Kantsevoy SV, Kethu SR, Kwon RS, Mamula P, Pedrosa MC, Rodriguez SA, Tierney WM, ASGE Technology Committee. Interventional EUS. Gastrointest Endosc. 2010 Jul; 72 (1):1-4 Epub 2010 Apr 09
    View PubMed
  281. Diehl DL, Tierney WM, Adler DG, Conway JD, Farraye FA, Kantsevoy SV, Kaul V, Kethu SR, Kwon RS, Mamula P, Pedrosa MC, Rodriguez SA, ASGE Technology Committee. The role of the U.S. Food and Drug Administration in device evaluation and monitoring. Gastrointest Endosc. 2010 Jul; 72 (1):5-10 Epub 2010 Apr 24
    View PubMed
  282. Wasan SK, Baker SE, Skolnik PR, Farraye FA. A practical guide to vaccinating the inflammatory bowel disease patient. Am J Gastroenterol. 2010 Jun; 105 (6):1231-8 Epub 2010 Jan 26
    View PubMed
  283. Rodriguez SA, Banerjee S, Desilets D, Diehl DL, Farraye FA, Kaul V, Kwon RS, Mamula P, Pedrosa MC, Varadarajulu S, Song LM, Tierney WM, Song LM, ASGE Technology Committee. Ultrathin endoscopes. Gastrointest Endosc. 2010 May; 71 (6):893-8
    View PubMed
  284. Kethu SR, Adler DG, Conway JD, Diehl DL, Farraye FA, Kantsevoy SV, Kaul V, Kwon RS, Mamula P, Pedrosa MC, Rodriguez SA, Tierney WM, ASGE Technology Committee. ERCP cannulation and sphincterotomy devices. Gastrointest Endosc. 2010 Mar; 71 (3):435-45
    View PubMed
  285. Farraye FA, Odze RD, Eaden J, Itzkowitz SH, McCabe RP, Dassopoulos T, Lewis JD, Ullman TA, James T 3rd, McLeod R, Burgart LJ, Allen J, Brill JV, AGA Institute Medical Position Panel on Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010 Feb; 138 (2):738-45
    View PubMed
  286. Farraye FA, Odze RD, Eaden J, Itzkowitz SH. AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010 Feb; 138 (2):746-74, 774.e1-4; quiz e12-3
    View PubMed
  287. Tierney WM, Adler DG, Conway JD, Diehl DL, Farraye FA, Kantsevoy SV, Kaul V, Kethu SR, Kwon RS, Mamula P, Pedrosa MC, Rodriguez SA, ASGE Technology Committee. Overtube use in gastrointestinal endoscopy. Gastrointest Endosc. 2009 Nov; 70 (5):828-34 Epub 2009 Aug 22
    View PubMed
  288. Noronha AM, Liang Y, Hetzel JT, Hasturk H, Kantarci A, Stucchi A, Zhang Y, Nikolajczyk BS, Farraye FA, Ganley-Leal LM. Hyperactivated B cells in human inflammatory bowel disease. J Leukoc Biol. 2009 Oct; 86 (4):1007-16 Epub 2009 July 09
    View PubMed
  289. Adler DG, Conway JD, Farraye FA, Kantsevoy SV, Kaul V, Kethu SR, Kwon RS, Mamula P, Pedrosa MC, Rodriguez SA, Tierney WM, ASGE Technology Committee. Biliary and pancreatic stone extraction devices. Gastrointest Endosc. 2009 Oct; 70 (4):603-9
    View PubMed
  290. Kwon RS, Wong Kee Song LM, Adler DG, Conway JD, Diehl DL, Farraye FA, Kantsevoy SV, Kaul V, Kethu SR, Mamula P, Pedrosa MC, Rodriguez SA, Tierney WM, ASGE Technology Committee. Endocytoscopy. Gastrointest Endosc. 2009 Oct; 70 (4):610-3
    View PubMed
  291. Kantsevoy SV, Adler DG, Conway JD, Diehl DL, Farraye FA, Kaul V, Kethu SR, Kwon RS, Mamula P, Rodriguez SA, Tierney WM, ASGE Technology Committee. Confocal laser endomicroscopy. Gastrointest Endosc. 2009 Aug; 70 (2):197-200 Epub 2009 June 25
    View PubMed
  292. Mamula P, Adler DG, Conway JD, Diehl DL, Farraye FA, Kantsevoy SV, Kaul V, Kethu SR, Kwon RS, Rodriguez SA, Tierney WM, ASGE Technology Committee. Colonoscopy preparation. Gastrointest Endosc. 2009 Jun; 69 (7):1201-9
    View PubMed
  293. Conway JD, Adler DG, Diehl DL, Farraye FA, Kantsevoy SV, Kaul V, Kethu SR, Kwon RS, Mamula P, Rodriguez SA, Tierney WM, Asge Technology Committee. Endoscopic hemostatic devices. Gastrointest Endosc. 2009 May; 69 (6):987-96
    View PubMed
  294. Diehl DL, Adler DG, Conway JD, Farraye FA, Kantsevoy SV, Kaul V, Kethu SR, Kwon RS, Mamula P, Rodriguez SA, Tierney WM, Asge Technology Committee. Endoscopic retrieval devices. Gastrointest Endosc. 2009 May; 69 (6):997-1003
    View PubMed
  295. Ullman T, Odze R, Farraye FA. Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohn's disease of the colon. Inflamm Bowel Dis. 2009 Apr; 15 (4):630-8
    View PubMed
  296. Farraye FA, Adler DG, Chand B, Conway JD, Diehl DL, Kantsevoy SV, Kwon RS, Mamula P, Rodriguez SA, Shah RJ, Wong Kee Song LM, Tierney WM, ASGE Technology Committee. Update on CT colonography. Gastrointest Endosc. 2009 Mar; 69 (3 Pt 1):393-8
    View PubMed
  297. Dendrinos K, Cerda S, Farraye FA. The "cecal patch" in patients with ulcerative colitis. Gastrointest Endosc. 2008 Nov; 68 (5):1006-7; discussion 1007 Epub 2008 July 11
    View PubMed
  298. Shah RJ, Adler DG, Conway JD, Diehl DL, Farraye FA, Kantsevoy SV, Kwon R, Mamula P, Rodriguez S, Wong Kee Song LM, Tierney WM, ASGE Technology Committee. Cholangiopancreatoscopy. Gastrointest Endosc. 2008 Sep; 68 (3):411-21 Epub 2008 June 05
    View PubMed
  299. Kantsevoy SV, Adler DG, Conway JD, Diehl DL, Farraye FA, Kwon R, Mamula P, Rodriguez S, Shah RJ, Wong Kee Song LM, Tierney WM, ASGE TECHNOLOGY COMMITTEE. Endoscopic mucosal resection and endoscopic submucosal dissection. Gastrointest Endosc. 2008 Jul; 68 (1):11-8
    View PubMed
  300. Yantiss RK, Das KM, Farraye FA, Odze RD. Alterations in the immunohistochemical expression of Das-1 and CG-3 in colonic mucosal biopsy specimens helps distinguish ulcerative colitis from Crohn disease and from other forms of colitis. Am J Surg Pathol. 2008 Jun; 32 (6):844-50
    View PubMed
  301. Conway JD, Adler DG, Diehl DL, Farraye FA, Kantsevoy SV, Kwon R, Mamula P, Rodriguez B, Shah RJ, Song LM, Tierney WM, Song LM, ASGE TECHNOLOGY COMMITTEE. Endoscopic electronic medical record systems. Gastrointest Endosc. 2008 Apr; 67 (4):590-4
    View PubMed
  302. Song LM, Adler DG, Conway JD, Song LM, Diehl DL, Farraye FA, Kantsevoy SV, Kwon R, Mamula P, Rodriguez B, Shah RJ, Tierney WM, ASGE TECHNOLOGY COMMITTEE. Narrow band imaging and multiband imaging. Gastrointest Endosc. 2008 Apr; 67 (4):581-9
    View PubMed
  303. Srivastava A, Redston M, Farraye FA, Yantiss RK, Odze RD. Hyperplastic/serrated polyposis in inflammatory bowel disease: a case series of a previously undescribed entity. Am J Surg Pathol. 2008 Feb; 32 (2):296-303
    View PubMed
  304. Isaacs KL, Sandler RS, Abreu M, Picco MF, Hanauer SB, Bickston SJ, Present D, Farraye FA, Wolf D, Sandborn WJ, Crohn's and Colitis Foundation of America Clinical Alliance. Rifaximin for the treatment of active pouchitis: a randomized, double-blind, placebo-controlled pilot study. Inflamm Bowel Dis. 2007 Oct; 13 (10):1250-5
    View PubMed
  305. Farraye FA, Waye JD, Moscandrew M, Heeren TC, Odze RD. Variability in the diagnosis and management of adenoma-like and non-adenoma-like dysplasia-associated lesions or masses in inflammatory bowel disease: an Internet-based study. Gastrointest Endosc. 2007 Sep; 66 (3):519-29 Epub 2007 July 20
    View PubMed
  306. Cole JA, Rothman KJ, Cabral HJ, Zhang Y, Farraye FA. Incidence of IBS in a cohort of people with asthma. Dig Dis Sci. 2007 Feb; 52 (2):329-35 Epub 2007 Jan 09
    View PubMed
  307. Hornick JL, Farraye FA, Odze RD. Clinicopathologic and immunohistochemical study of small apparently "de novo" colorectal adenocarcinomas. Am J Surg Pathol. 2007 Feb; 31 (2):207-15
    View PubMed
  308. O'Brien MJ, Yang S, Mack C, Xu H, Huang CS, Mulcahy E, Amorosino M, Farraye FA. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol. 2006 Dec; 30 (12):1491-501
    View PubMed
  309. Nadgir RN, Soto JA, Dendrinos K, Lucey BC, Becker JM, Farraye FA. MRI of complicated pouchitis. AJR Am J Roentgenol. 2006 Oct; 187 (4):W386-91
    View PubMed
  310. Cole JA, Rothman KJ, Cabral HJ, Zhang Y, Farraye FA. Migraine, fibromyalgia, and depression among people with IBS: a prevalence study. BMC Gastroenterol. 2006 Sep 28; 6:26 Epub 2006 Sept 28
    View PubMed
  311. Burakoff R, Barish CF, Riff D, Pruitt R, Chey WY, Farraye FA, Shafran I, Katz S, Krone CL, Vander Vliet M, Stevens C, Sherman ML, Jacobson E, Bleday R. A phase 1/2A trial of STA 5326, an oral interleukin-12/23 inhibitor, in patients with active moderate to severe Crohn's disease. Inflamm Bowel Dis. 2006 Jul; 12 (7):558-65
    View PubMed
  312. Dendrinos KG, Becker JM, Stucchi AF, Saubermann LJ, LaMorte W, Farraye FA. Anti-Saccharomyces cerevisiae antibodies are associated with the development of postoperative fistulas following ileal pouch-anal anastomosis. J Gastrointest Surg. 2006 Jul-Aug; 10 (7):1060-4
    View PubMed
  313. Fix OK, Simon JT, Farraye FA, Oviedo JA, Pratt DS, Chen WT, Cave DR. Obscure gastrointestinal hemorrhage from mesenteric varices diagnosed by video capsule endoscopy. Dig Dis Sci. 2006 Jul; 51 (7):1169-74
    View PubMed
  314. Liu TC, Amorosino MS, Cerda S, Farraye FA. Mycophenolate mofetil-associated enterocolitis. Gastrointest Endosc. 2006 Apr; 63 (4):707-8, discussion 708
    View PubMed
  315. Yantiss RK, Farraye FA, O'Brien MJ, Fruin AB, Stucchi AF, Becker JM, Reddy SI, Odze RD. Prognostic significance of superficial fissuring ulceration in patients with severe "indeterminate" colitis. Am J Surg Pathol. 2006 Feb; 30 (2):165-70
    View PubMed
  316. Hornick JL, Farraye FA, Odze RD. Prevalence and significance of prominent mucin pools in the esophagus post neoadjuvant chemoradiotherapy for Barrett's-associated adenocarcinoma. Am J Surg Pathol. 2006 Jan; 30 (1):28-35
    View PubMed
  317. Huang CS, Farraye FA. Complications following bariatric surgery. Techniques in Gastrointestinal Endoscopy. 2006; 8:54-65.
  318. Haskell H, Andrews CW Jr, Reddy SI, Dendrinos K, Farraye FA, Stucchi AF, Becker JM, Odze RD. Pathologic features and clinical significance of "backwash" ileitis in ulcerative colitis. Am J Surg Pathol. 2005 Nov; 29 (11):1472-81
    View PubMed
  319. Pabby A, Suneja A, Heeren T, Farraye FA. Flexible sigmoidoscopy for colorectal cancer screening in the elderly. Dig Dis Sci. 2005 Nov; 50 (11):2147-52
    View PubMed
  320. Lorber J, Kalish J, Farraye FA, Cerda S, Babineau TJ. Glomus tumor of the gastric antrum: case report. Curr Surg. 2005 Jul-Aug; 62 (4):436-8
    View PubMed
  321. Yung K, Oviedo J, Farraye FA, Becker JM, Andrews CW Jr, Lichtenstein D. Ampullary stenosis with biliary obstruction in duodenal Crohn's disease: a case report and review of the literature. Dig Dis Sci. 2005 Jun; 50 (6):1118-21
    View PubMed
  322. Emmons KM, McBride CM, Puleo E, Pollak KI, Marcus BH, Napolitano M, Clipp E, Onken J, Farraye FA, Fletcher R. Prevalence and predictors of multiple behavioral risk factors for colon cancer. Prev Med. 2005 May; 40 (5):527-34
    View PubMed
  323. Schroy PC 3rd, Lal SK, Wilson S, Heeren T, Farraye FA. Deficiencies in knowledge and familial risk communication among colorectal adenoma patients. J Clin Gastroenterol. 2005 Apr; 39 (4):298-302
    View PubMed
  324. Huang CS, Farraye FA. Endoscopy in the bariatric surgical patient. Gastroenterol Clin North Am. 2005 Mar; 34 (1):151-66
    View PubMed
  325. Huang CS, Lal SK, Farraye FA. Colorectal cancer screening in average risk individuals. Cancer Causes Control. 2005 Mar; 16 (2):171-88
    View PubMed
  326. Fix OK, Soto JA, Andrews CW, Farraye FA. Gastroduodenal Crohn's disease. Gastrointest Endosc. 2004 Dec; 60 (6):985
    View PubMed
  327. Yang S, Farraye FA, Mack C, Posnik O, O'Brien MJ. BRAF and KRAS Mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status. Am J Surg Pathol. 2004 Nov; 28 (11):1452-9
    View PubMed
  328. Huang CS, O'brien MJ, Yang S, Farraye FA. Hyperplastic polyps, serrated adenomas, and the serrated polyp neoplasia pathway. Am J Gastroenterol. 2004 Nov; 99 (11):2242-55
    View PubMed
  329. Yantiss RK, Sapp HL, Farraye FA, El-Zammar O, O'Brien MJ, Fruin AB, Stucchi AF, Brien TP, Becker JM, Odze RD. Histologic predictors of pouchitis in patients with chronic ulcerative colitis. Am J Surg Pathol. 2004 Aug; 28 (8):999-1006
    View PubMed
  330. Odze RD, Farraye FA, Hecht JL, Hornick JL. Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis. Clin Gastroenterol Hepatol. 2004 Jul; 2 (7):534-41
    View PubMed
  331. Farraye FA, Horton K, Hersey H, Trnka Y, Heeren T, Provenzale D. Screening flexible sigmoidoscopy using an upper endoscope is better tolerated by women. Am J Gastroenterol. 2004 Jun; 99 (6):1074-80
    View PubMed
  332. Mutinga ML, Odze RD, Wang HH, Hornick JL, Farraye FA. The clinical significance of right-sided colonic inflammation in patients with left-sided chronic ulcerative colitis. Inflamm Bowel Dis. 2004 May; 10 (3):215-9
    View PubMed
  333. Shaz BH, Reddy SI, Ayata G, Brien T, Farraye FA, Antonioli DA, Odze RD, Wang HH. Sequential clinical and histopathological changes in collagenous and lymphocytic colitis over time. Mod Pathol. 2004 Apr; 17 (4):395-401
    View PubMed
  334. O'Brien MJ, Yang S, Clebanoff JL, Mulcahy E, Farraye FA, Amorosino M, Swan N. Hyperplastic (serrated) polyps of the colorectum: relationship of CpG island methylator phenotype and K-ras mutation to location and histologic subtype. Am J Surg Pathol. 2004 Apr; 28 (4):423-34
    View PubMed
  335. Clipp EC, Carver EH, Pollak KI, Puleo E, Emmons KM, Onken J, Farraye FA, McBride CM. Age-related vulnerabilities of older adults with colon adenomas: evidence from Project Prevent. Cancer. 2004 Mar 1; 100 (5):1085-94
    View PubMed
  336. Glickman JN, Bousvaros A, Farraye FA, Zholudev A, Friedman S, Wang HH, Leichtner AM, Odze RD. Pediatric patients with untreated ulcerative colitis may present initially with unusual morphologic findings. Am J Surg Pathol. 2004 Feb; 28 (2):190-7
    View PubMed
  337. Sangha S, Soto JA, Becker JM, Farraye FA. Primary epiploic appendagitis: an underappreciated diagnosis. A case series and review of the literature. Dig Dis Sci. 2004 Feb; 49 (2):347-50
    View PubMed
  338. Farraye FA, Wong M, Hurwitz S, Puleo E, Emmons K, Wallace MB, Fletcher RH. Barriers to endoscopic colorectal cancer screening: are women different from men? Am J Gastroenterol. 2004 Feb; 99 (2):341-9
    View PubMed
  339. Huang CS, de las Morenas A, Farraye FA. Focal intestinal lymphangiectasia. Gastrointest Endosc. 2004 Jan; 59 (1):74
    View PubMed
  340. Huang CS, Forse RA, Jacobson BC, Farraye FA. Endoscopic findings and their clinical correlations in patients with symptoms after gastric bypass surgery. Gastrointest Endosc. 2003 Dec; 58 (6):859-66
    View PubMed
  341. Majumdar SR, Soumerai SB, Farraye FA, Lee M, Kemp JA, Henning JM, Schrammel P, LeCates RF, Ross-Degnan D. Chronic acid-related disorders are common and underinvestigated. Am J Gastroenterol. 2003 Nov; 98 (11):2409-14
    View PubMed
  342. Kissin EY, Corbo JC, Farraye FA, Merkel PA. Colchicine myopathy in a patient with familial Mediterranean fever and normal renal function. Arthritis Rheum. 2003 Aug 15; 49 (4):614-6
    View PubMed
  343. Stockwell DH, Woo P, Jacobson BC, Remily R, Syngal S, Wolf J, Farraye FA. Determinants of colorectal cancer screening in women undergoing mammography. Am J Gastroenterol. 2003 Aug; 98 (8):1875-80
    View PubMed
  344. Friedman S, Odze RD, Farraye FA. Management of neoplastic polyps in inflammatory bowel disease. Inflamm Bowel Dis. 2003 Jul; 9 (4):260-6
    View PubMed
  345. Eloubeidi MA, Wallace MB, Desmond R, Farraye FA. Female gender and other factors predictive of a limited screening flexible sigmoidoscopy examination for colorectal cancer. Am J Gastroenterol. 2003 Jul; 98 (7):1634-9
    View PubMed
  346. Yantiss RK, Odze RD, Farraye FA, Rosenberg AE. Solitary versus multiple carcinoid tumors of the ileum: a clinical and pathologic review of 68 cases. Am J Surg Pathol. 2003 Jun; 27 (6):811-7
    View PubMed
  347. Lembo A, Weber HC, Farraye FA. Alosetron in irritable bowel syndrome: strategies for its use in a common gastrointestinal disorder. Drugs. 2003; 63 (18):1895-905
    View PubMed
  348. Ayata G, Ithamukkala S, Sapp H, Shaz BH, Brien TP, Wang HH, Antonioli DA, Farraye FA, Odze RD. Prevalence and significance of inflammatory bowel disease-like morphologic features in collagenous and lymphocytic colitis. Am J Surg Pathol. 2002 Nov; 26 (11):1414-23
    View PubMed
  349. Sapp H, Ithamukkala S, Brien TP, Ayata G, Shaz B, Dorfman DM, Wang HH, Antonioli DA, Farraye FA, Odze RD. The terminal ileum is affected in patients with lymphocytic or collagenous colitis. Am J Surg Pathol. 2002 Nov; 26 (11):1484-92
    View PubMed
  350. Huang C, Lichtenstein DR, Farraye FA. Ureterosigmoidostomy. Gastrointest Endosc. 2002 Aug; 56 (2):272
    View PubMed
  351. Yantiss RK, Chang HK, Farraye FA, Compton CC, Odze RD. Prevalence and prognostic significance of acinar cell differentiation in pancreatic endocrine tumors. Am J Surg Pathol. 2002 Jul; 26 (7):893-901
    View PubMed
  352. Oviedo J, Barrison A, Farraye FA. Osler-Weber-Rendu syndrome. Gastrointest Endosc. 2002 Jun; 55 (7):910
    View PubMed
  353. Bernstorff WV, Glickman JN, Odze RD, Farraye FA, Joo HG, Goedegebuure PS, Eberlein TJ. Fas (CD95/APO-1) and Fas ligand expression in normal pancreas and pancreatic tumors. Implications for immune privilege and immune escape. Cancer. 2002 May 15; 94 (10):2552-60
    View PubMed
  354. Talwalkar JA, Ruymann FW, Marcoux P, Farraye FA. Recurrent thrombotic thrombocytopenic purpura (TTP) as a complication of acute relapsing pancreatitis. Dig Dis Sci. 2002 May; 47 (5):1096-9
    View PubMed
  355. Farraye FA, Wallace M. Clinical significance of small polyps found during screening with flexible sigmoidoscopy. Gastrointest Endosc Clin N Am. 2002 Jan; 12 (1):41-51
    View PubMed
  356. Rex DK, Chak A, Vasudeva R, Gross T, Lieberman D, Bhattacharya I, Sack E, Wiersema M, Farraye F, Wiersema M, Wallace M, Barrido D, Wallace M, Cravens E, Zeabart L, Bjorkman D, Lemmel T, Buckley S. Prospective determination of distal colon findings in average-risk patients with proximal colon cancer. Gastrointest Endosc. 1999 Jun; 49 (6):727-30
    View PubMed